Hybrid Imaging for the Detection of Obstructive Coronary Artery Disease by Joutsiniemi, Esa
A
N
N
A
LES U
N
IV
ERSITATIS TU
RK
U
EN
SIS
 Esa Joutsiniem
i
D
 1438
HYBRID IMAGING FOR THE 
DETECTION OF OBSTRUCTIVE 
CORONARY ARTERY DISEASE
 Esa Joutsiniemi
TURUN YLIOPISTON JULKAISUJA – ANNALES UNIVERSITATIS TURKUENSIS
SARJA - SER. D OSA  - TOM. 1438 | MEDICA - ODONTOLOGICA | TURKU 2019
ISBN 978-951-29-7724-6 (PRINT)
ISBN 978-951-29-7725-3 (PDF)
ISSN 0355-9483 (Print) ISSN 2343-3213 (Online)
Pa
in
os
al
am
a 
O
y, 
Tu
rk
u 
, F
in
la
nd
  2
01
9
TURUN YLIOPISTON JULKAISUJA – ANNALES UNIVERSITATIS TURKUENSIS 
SARJA - SER. D OSA – TOM. 1438 | MEDICA – ODONTOLOGICA | TURKU 2019 
 
 
 
Esa Joutsiniemi 
HYBRID IMAGING  
FOR THE DETECTION OF 
OBSTRUCTIVE CORONARY 
ARTERY DISEASE  
   
University of Turku 
Faculty of Medicine 
Cardiology and Cardiovascular Medicine,  
and Clinical Physiology and Isoptope Medicine 
Turku Doctoral Programme in Clinical Reseach 
Heart Centre and PET Centre 
Turku, Finland 
Supervised by 
Associate Professor Antti Saraste, MD, PhD Docent Heikki Ukkonen, MD, PhD 
Heart Centre and Turku PET Centre Heart Centre 
University of Turku University of Turku 
Turku, Finland Turku, Finland 
Reviewed by 
Docent Olli Anttonen, MD, PhD Docent Timo Mäkikallio, MD, PhD 
University of Oulu University of Oulu 
Päijät-Häme Central Hospital Oulu University Hospital 
Lahti, Finland Oulu, Finland 
Opponent 
Professor Jari Laukkanen, MD, PhD 
University of Jyväskylä 
Jyväskylä Central Hospital 
Jyväskylä, Finland 
 
 
 
 
The originality of this thesis has been checked in accordance with the University of 
Turku quality assurance system using the Turnitin Originality Check service. 
 
ISBN 978-951-29-7724-6 (PRINT) 
ISBN 978-951-29-7725-3 (PDF) 
ISSN 0355-9483 (Print) 
ISSN 2343-3213 (Online) 
Painosalama Oy – Turku, Finland 2019
 To Siiri and Alvar
 4
Esa Joutsiniemi 
Hybrid Imaging for the Detection of Obstructive Coronary Artery Disease 
University of Turku, Faculty of Medicine, Cardiology and Cardiovascular 
Medicine, and Clinical Physiology and Isotope Medicine, Turku Doctoral 
Programme in Clinical Reseach, Heart Centre and PET Centre, Turku, 
Finland  
ABSTRACT 
Coronary artery disease (CAD) is globally one of the leading causes of morbidity and 
mortality. CAD develops over decades when coronary arteries obstruct, typically 
causing chest pain symptoms and, in the worst case, death. Nowadays, obstructive CAD 
can be prevented and treated with modern and potent therapies; hence, accurate 
diagnostic tools have become more important. The aim of this thesis was to evaluate 
hybrid imaging techniques, i.e., combinations of two imaging techniques, for use in the 
detection of obstructive CAD. We evaluated the feasibility and accuracy of combined 
coronary computed tomography angiography (CTA) and either positron emission 
tomography (PET) myocardial perfusion imaging or coronary Doppler ultrasound to 
detect obstructive CAD in 107 symptomatic patents with an intermediate (30–70%) 
pretest probability of disease. Techniques were compared with invasive coronary 
angiography combined with physiological evaluation by fractional flow reserve. Our 
results showed that hybrid PET-CTA was highly accurate for detecting obstructive 
CAD and more accurate than either technique alone. Furthermore, measurement of 
myocardial blood flow by PET during vasodilator stress only was sufficient to evaluate 
the hemodynamic significance of coronary stenosis. We found that assessment of the 
coronary flow velocity profile at rest by Doppler ultrasound provides information on 
the hemodynamic significance of coronary stenosis identified by coronary CTA and 
may aid in detecting obstructive CAD. 
These results show the feasibility of hybrid imaging and demonstrate that it 
provides improved accuracy in detecting obstructive CAD as compared with stand-
alone coronary CTA. 
KEYWORDS: Coronary Artery Disease, Computed Tomography, Coronary 
Ultrasound, Positron Emission Tomography 
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Esa Joutsiniemi 
Hybridikuvantaminen ahtauttavan sepelvaltimotaudin diagnostiikassa  
Turun yliopisto, Lääketieteellinen tiedekunta, Kardiologia ja 
kardiovaskulaarilääketiede sekä Kliininen fysiologia ja isotooppilääketiede, 
Turun kliininen tohtoriohjelma, Sydänkeskus ja PET keskus, Turku, Suomi 
TIIVISTELMÄ 
Sepelvaltimotauti on yksi yleisimmistä kuolemaan johtavista sairauksista maailmassa. 
Tauti kehittyy vuosikymmenten aikana, jolloin sepelvaltimot ahtautuvat aiheuttaen 
taudille tyypilliset oireet. Nykyisillä, tehokkailla hoitomuodoilla tautia voidaan 
ennaltaehkäistä ja hoitaa, minkä vuoksi sairauden täsmällinen diagnostiikka on 
muodostunut entistä tärkeämmäksi. Tämän väitöskirjan tavoite oli tutkia 
hybridikuvantamisen, eli kahden eri kuvantamistutkimuksen yhdistelmän diagnostista 
osuvuutta ahtauttavan sepelvaltimotaudin toteamisessa oireisilla potilailla, joilla taudin 
todennäköisyys oli keskisuuri. Tutkimme sepelvaltimoiden tietokonetomografian (TT) 
ja joko positroniemissiotomografia (PET) -menetelmällä mitatun sydänlihaksen 
verenvirtauksen tai ultraäänellä mitatun sepelvaltimovirtausprofiilin yhdistelmää 107 
potilaan aineistossa. Kuvantamismenetelmiä verrattiin perinteiseen 
katetriangiografiaan, jota täydennettiin tarvittaessa sepelvaltimon sisäisellä 
painemittauksella. Tulokset osoittavat, että sepelvaltimoiden TT:n ja PET-kuvauksen 
yhdistelmä on tarkka menetelmä ahtauttavan sepelvaltimotaudin toteamisessa ja 
yhdistelmä on tarkempi kuin kumpikaan menetelmä yksin. Sydänlihaksen 
verenvirtauksen mittaaminen PET kameralla pelkän adenosiinirasituksen aikana ilman 
levossa tehtävää mittausta riittää ahtauttavan sepelvaltimotaudin toteamiseen. Lisäksi 
havaitsimme, että sepelvaltimon virtausprofiilin mittaaminen levossa Doppler-
ultraäänellä auttaa sepelvaltimoiden TT -kuvauksessa todetun ahtauman vaikeusasteen 
arvioinnissa ja voi auttaa taudin diagnostiikassa. 
Hybridikuvantaminen parantaa ahtauttavan sepelvaltimotaudin diagnostiikkaa 
verrattuna pelkkään sepelvaltimoiden TT-kuvaukseen. Hybridikuvantaminen on 
toteutettavissa kliinisessä diagnostiikassa. 
AVAINSANAT: sepelvaltimotauti, tietokonetomografia, sepelvaltimoultraääni, 
positroniemissiotomografia  
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1 Introduction 
Coronary artery disease (CAD) is one of the leading causes of morbidity and 
mortality in Western countries (GBD 2016 Causes of Death Collaborators). 
Assessment of symptoms and risk factors of cardiovascular disease are important in 
evaluation of the likelihood of obstructive CAD (Diamond and Forrester, 1979; 
Pryor et al., 1983). However, accurate diagnostic tools for CAD detection are needed 
to efficiently target therapies of CAD. Over 70 years ago (1942), Arthur M. Master 
developed an exercise electrocardiography (ECG) test for medical use to recognize 
obstructive CAD (Wener et al., 1953). Since then, the CAD diagnosis has been 
mainly based on clinical history, a positive exercise ECG test and an invasive 
coronary angiography (ICA). Non-invasive diagnostic CAD tests that are based on 
imaging have developed fast recently. The first rotating gamma camera was invented 
in 1977, which permitted detection of flow-limiting CAD by myocardial perfusion 
imaging with single-photon emission computed tomography (SPECT) (Hutton, 
2014). The milestone of cardiac computed tomography imaging was the 
introduction of single-slice helical CT systems into clinical practice in 1996, when 
the ability to image the heart was dramatically improved. The shorter gantry 
rotation time led to better image quality and the use of ECG gating further improved 
the image quality by targeting the imaging in mid-diastolic phase when the cardiac 
movement is minimal (Hurlock et al., 2009).  
The first successful clinical coronary artery bypass grafting (CABG) was made by 
a team led by Robert H. Goetz in the United States on May 2, 1960, to a 38-year-old 
man with obstructive CAD (Goetz et al., 1961). Andreas Gruentzig performed the 
first successful percutaneous transluminal coronary angioplasty (PTCA; at present 
percutaneous coronary intervention (PCI)) in Zürich on September 16, 1977. The 
procedure was performed to a symptomatic patient after a positive exercise test with 
favourable long-term follow-up results (Gruentzig, 1978; Gruentzig et al., 1987; 
King 3rd and Schlumpf, 1993). Revascularization by either PCI or CABG has 
proven effective in improving CAD symptoms and they also provide prognostic 
benefit in some patient subgroups (Montalescot et al, 2013). 
Recent studies demonstrate that the benefits of PCI are limited to the treatment 
of flow-limiting stenoses (Pijls et al., 2007; Tonino et al., 2010; Windecker et al., 2014; 
Mancini et al., 2014). These findings have generated a need for better non-invasive 
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tools to assess the hemodynamic significance of stenoses detected in coronary 
arteries (Tonino et al., 2009; Tavakol et al., 2012). 
Modern multidetector computer tomography equipment has emerged in the 
diagnostic field of cardiac imaging. It is possible to visualize coronary arteries and 
atherosclerotic lesions by coronary CT angiography (CTA) and reliably exclude 
obstructive CAD. However, CTA has only limited diagnostic value when estimating 
the hemodynamic significance of stenosis (Gibbons 2008). Therefore, there is a need 
for additional imaging techniques to discriminate between flow-limiting and non-
flow-limiting stenoses. It has been pointed out since the 1980s that myocardial 
perfusion can be evaluated by positron emission tomography (PET) (Hack et al., 
1980; Bergmann et al., 1984). Myocardial ischemia is visualized in perfusion imaging 
by reduced tracer uptake during stress, compared to the uptake at rest. When CT 
and PET technology improved to the current state, it became possible to combine 
the CT and either PET or SPECT as hybrid scanners and to perform both scans 
consecutively. 
The usefulness of Doppler ultrasound for detection of flow-limiting coronary 
artery stenosis was demonstrated nearly 20 years ago (Hozumi et al., 2001; Higashiue 
et al., 2001). This method has rarely been used in clinical practice because of the need 
for special skills and its limited ability to visualize the right coronary artery (RCA) 
and the left circumflex artery (LCX) due to their anatomic course (Saraste et al., 
2005).  
In spite of this progress there is a clinical need to develop better noninvasive 
diagnostic tools to diagnose CAD. Hybrid imaging combining visualization of 
coronary anatomy and evaluation of functional consequenses of coronary stenoses 
is a very promising concept in addressing this need. In our study, we have evaluated 
combined coronary CTA and either PET perfusion imaging or coronary ultrasound 
to detect hemodynamically significant CAD. In order to apply these methods in 
clinical decision making information on their feasibility and diagnostic performance 
is needed.    
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2 Review of Literature 
2.1 Coronary artery disease 
Coronary artery disease (CAD) is caused by atherosclerosis of the coronary arteries. 
It is usually a slowly developing process, starting in adolescence and continuing 
throughout one’s lifetime. In the beginning, macrophages at the inner wall of the 
artery (intima) collect LDL-cholesterol, causing atherosclerotic plaque formation at 
a rate that depends on an individual’s risk factor levels (Kovanen, 2016). 
Symptomatic CAD develops when an atherosclerotic plaque leads to a narrowing of 
a coronary artery (stenosis) and to reduced blood flow to the myocardium, causing 
an imbalance between the delivery and need for oxygen (ischemia) and nutrients. 
Myocardial ischemia causes the symptoms of CAD. The main symptom is 
discomfort or pain in the chest (angina pectoris). In some patients, ischemia can also 
be caused by spasm of a normal or atherosclerotic artery or dysfunction of the small 
arteries. Ischemia can also present as left ventricular dysfunction caused by prior 
myocardial necrosis, myocardial stunning or hibernation. These mechanisms may 
act independently or in combination. When ischemia is provoked by physical or 
emotional stress, the condition is called stable coronary artery disease (SCAD). 
The prevalence of SCAD in population-based studies varies from 4-14%; the 
variation is mainly caused by age and sex. The prevalence increases with age in both 
sexes (Montalescot et al., 2013). The most common risk factors linked to the 
prevalence of SCAD are age, family history, hypertension, hypercholesterolemia, 
diabetes, obesity, smoking and sedentary lifestyle (Piepoli et al., 2016).  
SCAD often appears as a chronic situation in which myocardial ischemia causes 
typical symptoms (as mentioned above) or heart failure. When rupture of a plaque 
causes coronary thrombosis and myocardial infarction (MI), the symptoms start or 
progress rapidly, and the situation is then called acute coronary syndrome (ACS). 
The term ACS is used to describe a broad spectrum of clinical conditions, from 
unstable angina pectoris to ST-segment elevation MI in ECG, which are all due to a 
continuum of myocardial ischemia. MI is defined as evidence of myocardial necrosis 
in a clinical setting consistent with acute myocardial ischemia and detection of 
changes in cardiac biomarker levels (e.g., cardiac troponin (cTn)); and with 1) 
symptoms of ischemia, 2) new ECG changes (ST-T, new LBBB, Q-waves), 3) imaging 
finding of new loss of myocardium or wall motion abnormality or 4) identification 
Review of Literature 
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of intracoronary thrombus (Thygesen et al., 2012). The prognosis of CAD is highly 
variable, depending on risk factors, and it is very important to identify patients who 
benefit from aggressive preventive therapy and interventions, and, conversely, 
patients with a good prognosis. The reliable detection of ischemia has an important 
role in the evaluation of prognosis. 
2.2 Diagnosis of coronary artery disease 
Diagnosing SCAD is often a complex task that involves not only clinical evaluation 
of symptoms and risk factors but also diagnostic tests demonstrating either 
myocardial ischemia or coronary stenosis (Montalescot, 2013).  
Clinical history is the cornerstone of the diagnosis. Risk factors alone provide a 
reasonable estimate on the probability of SCAD, but the nature of symptoms is more 
important. Discomfort of the chest can be evaluated by four characteristics: location, 
character, duration and relation to exertion. Myocardial ischemia usually causes 
discomfort in the chest, but it may be felt between epigastrium to jaw and radiate to 
back or arm. Typical ischemic pain is dull, often described as pressure or tightness, 
and it will not last over 10 minutes in the majority of cases. Chest pain caused by 
SCAD is typically related to exercise or emotional stress, and relieved at rest or by 
administration of sublingual nitrate. This classic symptom is called angina pectoris 
(Diamond, 1983; Fox et al. 2006). 
Because chest pain is a very common symptom, clinical prediction models have 
been developed to estimate the probability of obstructive CAD. As early as 1979, 
Diamond and Forrester showed the importance of age, sex and symptoms in 
predicting obstructive CAD (Diamond and Forrester, 1979). In 1983 Pryor and his 
colleagues added risk-factors (smoking, hyperlipidemia, hypertension, diabetes and 
family history) to the earlier Diamond-Forrester-model and developed a better 
model to predict likelihood for CAD, called the Duke Clinical Score (DCS) (Pryor et 
al., 1983). Current clinical guidelines recommend the use of pretest probability 
(PTP) estimates based on age, gender and type of chest pain that were updated with 
the prevalence of CAD in a more recent population than the original Diamond and 
Forrester model (Montalescot 2013, Genders 2011). This update and more recent 
studies indicate that the prevalence of CAD has decreased over time (Cheng 2011). 
Recent studies also indicate that information on coronary calcium can refine 
estimates of pretest probability (Genders, 2012). 
If diagnosis of CAD remains uncertain after clinical evaluation, objective 
findings of stenosis or myocardial ischemia are needed to verify the diagnosis. Non-
invasive diagnostic tests perform best when PTP is between 15-85%, i.e., from low-
intermediate to high-intermediate. In current clinical practice guidelines exercise 
ECG or functional imaging tests detecting myocardial ischemia are recommended as 
the first line test in patients with a PTP of 15-85%. Coronary CTA can be considered 
Esa Joutsiniemi 
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as an alternative to these in patients with a PTP of 15–50%. Coronary CTA has a high 
negative predictive value and can be used to exclude obstructive CAD. If the 
symptoms are non-cardiac and PTP is < 15%, other causes of chest pain than CAD, 
such as gastrointestinal, musculoskeletal or pulmonary causes should be considered. 
Conversely, if the PTP is > 85%, the CAD diagnosis can be made clinically, and 
further testing will not improve accuracy; however, diagnostic tests are 
recommended for risk stratification purposes. Proceeding directly to ICA is a 
reasonable option if symptoms do not respond to medical therapy or if non-invasive 
tests indicate a high risk of adverse cardiac events (Montalescot et al., 2013). ICA 
may also be an option if non-invasive test are inconclusive. Taken together, non-
invasive tests are recommended in patients an intermediate PTP of flow-limiting 
CAD. The detection of ischemia in non-invasive tests is based on ECG chances, 
abnormal perfusion or myocardial function during stress. Perfusion imaging 
techniques are described in section 2.6. Anatomic testing with CTA is also an option, 
especially when PTP is low-intermediate (15-50%). Depending on the PTP estimate, 
risk factors, symptoms, other findings, and availability, a test that performs best is 
individually chosen. 
2.3 Electrocardiogram exercise testing 
Using 12-lead ECG monitoring (exercise ECG) in patients with suspected SCAD and 
a moderate PTP bicycle exercise testing is a useful option because of its simplicity 
and availability. In addition to the diagnosis, the stress test also provides prognostic 
information. During the stress test, the clinician can evaluate symptoms of the 
patients, blood pressure response, physical state and heart rate response, which are 
useful information in clinical decision-making.  
Acquiring the best diagnostic information from an exercise ECG means that it 
must be symptom- and sign-limiting and without influence of an anti-ischemic drug. 
The main diagnostic abnormality is a form of horizontal or down-sloping ST-
segment depression in one or more ECG-leads. The ST-depression must be ≥ 0.1mV 
or ≥ 1mm to specify a positive test (and diagnose significant CAD), and a specificity 
of 85-90% and sensitivity of 45-50% were reported with these values (Froelicher et 
al., 1998; Morise and Diamond, 1995). Exercise ECG is not diagnostic for CAD in 
the presence of resting ECG changes that preclude evaluation of ischemia, such as 
left bundle branch block (LBBB), Wolf-Parkinson-White syndrome (WPW) or 
ventricular paced rhythm. In addition, false positive results are more common in the 
presence of left ventricular hypertrophy, atrial fibrillation, electrolyte disorders, 
digitalis use and in patients with intraventricular conduction abnormalities other 
than LBBB (Pradhan et al., 2012). The exercise testing is also less sensitive and 
specific in women for unknown reasons (Morise and Diamont, 1995; Okin and 
Kligfield, 1995). 
Review of Literature 
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2.4 Computed tomography angiography 
The first clinical studies with computed tomography angiography (CTA) imaging 
were performed almost 40 years ago (Guthaner et al., 1979). With the development 
of techniques and CT scanners, the CTA has gradually provided increasingly better 
possibilities to visualize the heart’s anatomy, especially coronary arteries. The 64-row 
multi-detector CT has made it possible to reduce the imaging time and allow imaging 
of small coronary arteries with very high resolution (< 1mm). The use of a contrast 
medium allows direct visualization of coronary arteries, and cardiac motion can be 
stopped for analysis with the use of ECG gating. First clinical studies have already 
shown that coronary CTA can rule out the presence of CAD reliably (Nieman et al., 
2002), but hemodynamically significant CAD was more difficult to detect, and 
positive predictive value (PPV) has been only moderate (Abdulla et al., 2007; Di 
Tanna et al., 2008; Mowatt et al., 2008). In 2008 Mowatt and his colleagues published 
a review article that included 40 studies, 28 of which provided sufficient data for 
inclusion in the meta-analysis, all using ≥ 50% stenosis to define CAD. In that 
analysis, the sensitivity of coronary CTA for detecting CAD (≥ 50% stenosis by ICA) 
was 99%, specificity 89%, median PPV across studies was 93% (range 64-100%) and 
NPV was 100% (range 86-100%). The results were 90%, 97%, 76% (44-93%) and 99% 
(95-100%), respectively, when analyzing segment based. Sensitivity, specificity, PPV 
and NPV were 95%, 83%, 64% and 99%, respectively, for detecting ≥ 50% stenosis in 
another prospective, multi-center study (Budoff et al., 2008) in patient-based 
analysis. This indicates that coronary CTA is an excellent tool to exclude CAD, but 
it has limited accuracy for analyzing the hemodynamic relevance of stenosis, because 
angiographic severity is a poor predictor of hemodynamic significance (Gaemperli 
et al., 2012). A recent meta-analysis confirmed that from non-invasive diagnostic 
tools, CTA performed best to detect anatomically significant CAD, but functional 
tests perform better in detecting functionally significant CAD (Knuuti et al., 2018). 
After introduction of high-end, multi-detector CT scanners, the image resolution 
has been shown to be sufficient for evaluating even small coronary arteries (diameter 
< 1,5mm) (Koepfli et al., 2004).  
A large study of over 9000 patients proved that CTA alone provides better 
prognostic information than functional testing in patients who have stable chest pain 
with low or intermediate risk for obstructive CAD (Hoffmann et al., 2017). Even with 
new CT scanners, the amount of false positive and false negative results increase 
when diagnosing patients with a body mass index over 30 kg/m². Patients with a high 
calcium score (over 400) and heart rate over 70 beats per minute also increase the 
number of artefacts and remain challenging to diagnose. (Raff et al., 2005; Meijboom 
et al., 2008, Gueret et al., 2013). In a prospective, multicenter, randomized controlled 
trial with 4146 patients, Williams et al. (2016) compared standard care or standard 
care plus CTA to guide management of patients with coronary disease. They 
demonstrated that CTA can be used not only to rule out hemodynamically 
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significant CAD but also to guide management of patients with CAD. Furthermore, 
the study showed a significantly lower rate of the combined end-point of 
cardiovascular death or non-fatal myocardial infarction (2.3% vs. 3.9% during 5-year 
follow-up) in patients who had coronary CTA performed in addition to the routine 
testing, which consisted predominantly of exercise ECG in that study (Williams 
2018).  
2.5 Invasive coronary angiography 
Invasive coronary angiography (ICA) has been regarded as the gold standard of CAD 
diagnosis. The definition of CAD is when a patient has a symptom caused by CAD 
with an objective finding of myocardial ischemia and/or flow-limiting coronary 
artery stenosis. The coronary anatomy and possible coronary stenosis can be 
visualized using ICA with injection of a contrast media via catheter to a coronary 
artery. Because of complication risks (i.e., allergic reactions from contrast media or 
the local anesthesia agent, contrast-induced nephropathy, cholesterol emboli, 
vascular injury and bleeding at the puncture site, brady- and tachyarrhythmia, MI, 
cerebrovascular complications, perforation of great vessels and death) (Tavakol et 
al., 2012), ICA is usually performed after noninvasive testing in patients with 
suspected SCAD. ICA can be performed without noninvasive testing to verify CAD 
if a person has low ejection fraction (<50%) and typical angina pectoris, high event 
risk or other diagnostic methods are not possible (Montalescot et al., 2013).  
ICA is also the preferred investigation procedure in situations when a patient has 
high PPV for CAD and severe symptoms, an acute coronary syndrome (e.g., 
myocardial infarction with or without ST-elevation) or if a coronary intervention is 
needed. Bavry et al. (2006) and Elgendy and colleagues (2016) have shown that 
routine invasive strategy improves long-term survival and reduces the risk of 
ischemic events in non-ST-elevation infarction.  
Even if ICA has been regarded as the gold standard, its limitations are similar to 
CTA’s in that it provides only morphological information about the degree of 
stenosis. Furthermore, because of ICA’s risks, a clinical need exists for accurate, 
noninvasive methods to diagnose hemodynamically significant CAD. 
2.5.1 Invasive fractional flow reserve 
Pijls and colleagues derived and published in 1993 a simple principle called fractional 
flow reserve (FFR), which is based on the fundamentals of fluid dynamics (Pijls et 
al., 1993, Pijls et al., 1995). It has become a useful method for aiding decision making 
on revascularization because of the fact that only part of the angiographic visualized 
50% - 90 % stenosis are functionally flow limiting, and outcome studies show the 
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positive effect of FFR-guided revascularization on clinical outcomes  (Pijls et al., 
2005; Tonino et al., 2009; Tonino et al., 2010; van Nunen et al., 2015).  
FFR is defined as the ratio of distal coronary pressure to aortic pressure during 
the maximal hyperemic state, and it is independent of changes in hemodynamics, 
microcirculation and basal flow. The normal FFR is 1, because pressure in a normal 
coronary artery should equal aortic pressure throughout the artery (Pijls et al., 1993). 
The FFR ≤ 0.80 is considered to best identify a coronary stenosis with hemodynamic 
significance. When FFR is used together with routine angiography in decision 
making for coronary stenting, it reduces mortality, rate of myocardial infarction and 
rate of repeat revascularization compared with standard angiography-guided 
angioplasty (Tonino et al., 2009; Pijls et al., 2010; van Nunen et al., 2015). 
FFR measurement is an excellent tool for estimating the hemodynamic 
significance of stenosis and is recommended for routine use when considering 
coronary angioplasty, unless the stenosis is not clearly visually significant (> 90%) or 
non-significant (< 30%) (Tonino et al., 2010). Thereby, the clinical outcome is also 
achieved with a lower number of stented arteries and less resource use (Tonino et al., 
2010; van Nunen et al., 2015).  
2.6 Functional tests of myocardial ischemia 
Currently, there are various imaging techniques available to detect myocardial 
ischemia. Ischemia testing with imaging can be done with pharmacologic stress and, 
therefore, used for patients with diminished tolerance to physical stress. Imaging is 
also recommended for patients with abnormal resting electrocardiogram, or an 
intermediate or high probability to CAD (Cremer et al., 2014). When Dehmer et al. 
(2012) analyzed the United State’s National Cardiovascular Registry data from 
January 2010 to June 2011, they noticed that less than half of patients undergoing 
ICA had had a previous non-invasive diagnostic test of CAD. Over 90% of the 
patients tested before ICA had undergone a functional test, mostly stress myocardial 
perfusion imaging (81%). Ten percent had undergone a stress echocardiogram and 
the rest had an exercise ECG. SPECT and PET perfusion imaging were the most 
commonly used myocardial perfusion imaging techniques and their advantages and 
disadvantages are described below. 
2.6.1 Single-photon emission computed tomography 
(SPECT) 
SPECT myocardial perfusion imaging (MPI) has been widely used for almost 40 
years and has proven in many publications to have both diagnostic and prognostic 
value (Verberne, 2015). The diagnosis of ischemia using SPECT imaging is based on 
imaging tracer uptake in the myocardium that reflects relative myocardial blood 
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flow. Myocardial ischemia is visualized by reduced tracer uptake during stress, 
compared to the uptake in rest. The most commonly used tracers are Technetium-
99m based tracers, and they are used with a symptom-limited exercise test; a 
pharmacological test is an option if the patient is unable to perform the exercise test 
(Verberne, 2015). A pharmacological stress test uses the vasodilators adenosine or 
dipyridamole to produce hyperemia of the myocardium to mimic stress perfusion of 
the myocardium. If adenosine is contraindicated (because of asthmatic 
bronchospasm), either dobutamine or regadenoson is an alternative stressor. 
Regadenoson, the selective adenosine A2A receptor agonist, can be dosed as a single 
bolus and is more specific to the A2A receptor. Therefore, it causes selective coronary 
vasodilatation with lesser side effects (such as AV-block, angina pectoris, dyspnea, 
flushing and headache) (Cerqueira, 2006).  
Like other imaging techniques, SPECT provides a more sensitive prediction of 
the presence of CAD than does an exercise ECG alone (Montalescot et al., 2013; 
Knuuti et al, 2018). In 2012 Jaarsma and her colleagues performed a large meta-
analysis from 114 SPECT studies that demonstrated the sensitivity of 88% and 
specificity of 61% in a patient-based analysis. In a vessel-based analysis sensitivity 
and specificity were 69% and 79%, respectively. SPECT also has disadvantages, and 
it is recognized that SPECT can underestimate the extent of ischemia, especially in 
multivessel disease. SPECT protocol also takes much more time than other MPI 
techniques (up to 4 hours), and attenuation artifacts and GI tracer interferences are 
common. (Heller et al., 2009)   
2.6.2 Positron emission tomography perfusion imaging 
Positron emission tomography (PET) is based on short-lived positron emitting 
radionuclides. PET has been used for myocardial imaging for over 40 years (Hack et 
al., 1980; Bergmann et al., 1984). By the end of the 1980s, the first human studies had 
been published indicating that PET offers the possibility to measure quantitative 
myocardial blood flow (Bergmann et al., 1989).  
PET myocardial perfusion imaging techniques were developed during the last 
decade, and its clinical usefulness in CAD detection has been studied extensively 
(Jaarsma 2012, Knuuti 2018). Its image quality is better when compared to SPECT, 
its imaging protocol is shorter, and its diagnostic accuracy is higher (Bateman et al., 
2006; Heller et al., 2009). A meta-analysis of 19 publications demonstrated that PET 
has high diagnostic accuracy with 92% sensitivity and 85% specificity (Nandalur et 
al., 2008). Similar results have been achieved with PET/CT instrumentations with 
different tracers (Samson et al., 2007). In 2012 Jaarsma et al. found, in a meta-
analyses of 166 articles of different myocardial perfusion methods, that PET achieved 
the best diagnostic performance over both SPECT and cardiac magnetic resonance 
imaging, with a pooled sensitivity of 84% and specificity 81%. 
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A systematic review summarized the available literature on the prognostic value 
of PET perfusion imaging (Dorbala, 2013). The prognostic value of PET perfusion 
imaging has been demonstrated in several single-center studies and a large recent 
multicenter registry study of PET perfusion imaging (Dorbala, 2012). The prognostic 
value of PET perfusion imaging is also validated in several unique subsets of patients.  
The tracers have differences in myocardial uptake, myocardial extraction 
fraction, half-life, positron range, production and use in clinical setting. Nowadays 
there are three commonly used myocardial perfusion tracers in PET imaging: ¹5O 
water, ¹³N ammonia and 8²Rubidium. In clinical settings the key differences between 
the tracers for diagnosing CAD depend on myocardial uptake and extraction 
fraction. In ¹5O water the myocardial tracer does not accumulate in myocardium. 
Quantitative modeling is possible and interpretation is straightforward, since the 
uptake is linear dependent on myocardial blood flow; if the tracer uptake is 25% less 
from normal, the myocardial blood flow is 25% lower than normal region as 
illustrated in Figure 1 (Knuuti et al, 2009; Knuuti and Saraste, 2012; Maddahi and 
Packard, 2014). PET tracers do not allow imaging in combination with a treadmill 
exercise test because of short half life. A pharmacological stress is used, instead. 
 
Figure 1. Graphical presentation of the relationship between absolute myocardial perfusion and 
tracer uptake. Reproduced with permission from J Nucl Cardiol. 2009 Jul-Aug;16(4):497–506. doi: 
10.1007/s12350-009-9101-1. Epub 2009 Jun 3. 
Modern PET scanners have enabled measurements of myocardial perfusion in 
absolute terms when evaluating patients with suspected CAD (Groves et al., 2009, 
Knuuti and Saraste, 2012). Reduced myocardial flow reserve (MFR), defined as the 
ratio of maximal myocardial blood flow (MBF) at stress to basal MBF at rest, is used 
as a marker of the hemodynamically significant coronary artery stenosis (Uren et al., 
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1994; DiCarli et al., 1995; Murthy et al., 2011). Later studies have established that 
MBF alone during vasodilator stress is accurate and sufficient for CAD detection in 
patients with no previous myocardial infarction (Hajjiri et al., 2009; Danad, 2017). 
When measuring myocardial blood flow during adenosine induced hyperemia, 
studies have shown that the MBF value < 2.5 ml/g/min gives the best combination of 
sensitivity and specificity with diagnosing occlusive CAD (Kajander et al., 2011). 
Recent studies by Danad et al. (2014) indicated that MBF value under 2.3 ml/g/min 
gives even better accuracy in diagnosing obstructive CAD. 
Studies have also shown that quantitative MBF by PET scanner provides 
prognostic information on CAD and is an independent predictor of major cardiac 
event and cardiac mortality of patients with known or suspected CAD (Yoshinaga et 
al., 2006; Herzog et al., 2009; Murthy et al., 2011; Ziadi et al., 2011). 
2.6.3 Stress echocardiography 
Stress echocardiography remains an important tool in functional testing of 
myocardial ischemia (Sicari et al., 2009). It is an established technique that 
encompasses two-dimensional echo imaging of wall motion, and also color Doppler 
imaging, during exercise or pharmacological stress agent infusion. Stress 
echocardiography provides important information on the structure of heart, global 
and segmental functions during rest and stress, information about valvular function, 
pulmonary hypertension, diastolic dysfunction, and hypertrophic myocardial 
diseases, and it also has prognostic value (Tweet et al., 2015). While conventional 
exercise ECG has only moderate sensitivity and specificity, the exercise testing with 
echocardiography gives better diagnostic accuracy and more information about 
presence and location of myocardial ischemia (Gibbons et al., 1997; Fox et al. 2006). 
Pooled sensitivity and specificity of stress echocardiography are reported as 81% and 
86%, respectively (Mieres et al., 2005; Fox et al., 2006). 
Physical exercise is (usually) performed via treadmill or bicycle in either supine 
or upright positions. Pharmacological stress agents can be used if the patient is 
unable to perform an exercise test. Dobutamine is the most often-used stress agent; 
dipyridamole or adenosine are less frequently used alternatives. Myocardial ischemia 
leads to abnormal wall motion during exercise detected in echocardiography. 
Exercise capacity/tolerance also provides important prognostic information, and it 
has been reported that the pharmacological stress echocardiography test has lower 
sensitivity and specificity compared with the use of physical exercise in single- and 
multivessel CAD, and there appear to be no significant differences between men and 
women (Mieres et al., 2005). Performing stress echocardiography requires expertise 
and experience and is more user-dependent than other diagnostic imaging 
techniques of CAD; the echocardiographic image quality also varies depending on 
patient characteristics. 
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2.6.4 Coronary ultrasound 
The first in vivo description of blood flow disturbance at a site of coronary stenosis 
by transthoracic Doppler echocardiography (TTDE) and the first transthoracic 
evaluation of the hemodynamic effects of a coronary artery stenosis in humans were 
made over 20 years ago (Kenny et al., 1992). The measurements are based in Doppler 
phenomena arising from the change in the frequency of a sound wave due to a 
reflector moving towards or away from transducer. All potential ultrasound-
windows are used to locate the coronary arteries in a coronary ultrasound study. The 
normal coronary flow velocity is lower than intracardiac blood flow velocities, and 
the color Doppler flow mapping scale must be adjusted between 9 cm/s to 24 cm/s 
to visualize the coronary blood flow in diastole (Hozumi et al., 1998).  
A flow-limiting coronary artery stenosis causes local acceleration and turbulence 
of the flow at the site of stenosis and is detectable by TTDE (Kenny et al., 1992). It is 
possible to measure myocardial flow velocity reserve (CFVR, i.e., the ratio between 
rest and maximal coronary flow velocity during vasodilator-induced hyperemia) in 
the distal coronary artery (Hozumi et al., 2001; Matsumura et al., 2003). The CFVR 
< 2.0 implies that stenosis is hemodynamically significant and flow limiting (Kern et 
al., 2006). Other methods include measurement of flow velocity at the site of stenosis 
and compare it with non-accelerated, pre-stenosis values when evaluating suspected 
stenosis in the coronary artery. Maximal-to-pre-stenosis ratio (M/P) over 2.0 to 2.2 
has been shown as a cut-off value for over 50% stenosis, as diagnosed by quantitative 
coronary angiography (Holte et al., 2015).  
Previous studies have reported the usefulness of coronary ultrasound for stenosis 
detection in the LAD (Hozumi et al. 1998; Hozumi et al., 2001; Higashiue et al., 2001) 
and also good sensitivity (74-86%) and specificity (92-96%) (Hozumi et al., 2001; 
Caiati et al., 2009; Holte et al., 2015). Both feasibility and the number of correctly 
diagnosed stenosis have been lower, (34-63%) and (37-40%), respectively, in the 
RCA and LCX (Saraste et al., 2005; Holte et al., 2015).  
The major limitation of TTDE for routine use when imaging coronary stenosis 
is its poor diagnostic accuracy with RCA and LCX because of their anatomic course 
and variations (Saraste et al., 2005). The key is to use all possible standard and non-
standard windows and views to visualize RCA and LCX. Specific skills and expert 
knowledge of coronary anatomy and imaging is needed, which limits the usefulness 
of TTDE in daily clinical work. The usefulness of detecting stenosis in the LAD is 
commonly reported (Hozumi et al., 2001; Holte et al., 2015). Its other limitation is 
the variance in angle between coronary blood flow and Doppler beam, leading to 
errors in flow velocity measurements. Similarly, filling pressure, hypertrophy and 
regional contractility may affect the results (Holte et al., 2015). Numerous reports 
have been published on the good feasibility and diagnostic technique for the flow 
limiting stenosis in LAD (Kenny et al., 1992; Hozumi et al., 1998, Krzanowski et al., 
2000; Saraste et al., 2000; Saraste et al., 2005). The success rate for analyzing LCX and 
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RCA has been limited because of anatomic obstacles (Krzanowski et al., 2003; Saraste 
et al., 2005; Vegsundvåg et al., 2009). CTA combined with coronary ultrasound has 
also led to better PPV with finding of hemodynamically significant coronary/intra-
coronal plaque (Pizzuto et al., 2009). 
2.7 Hybrid imaging 
The term hybrid imaging means the combination of information obtained with 
different imaging techniques into a single study (Gaemperli et al., 2012). Coronary 
CTA gives an estimate of the degree of atherosclerotic burden and can rule out 
hemodynamically significant coronary artery disease, although it fails to determine 
the functional significance of coronary stenosis. Coronary CTA was combined with 
SPECT in 2007 to allow better evaluation of the spatial relationship between 
coronary stenosis and perfusion defects. Hybrid SPECT/CT yielded sensitivity, 
specificity, NPV, PPV and accuracy for the detection of any myocardial perfusion 
defect by patient (75%, 90%, 93%, 68% and 87%, respectively) (Gaemperli et al., 
2007). The major limitation of SPECT is that it only allows measurement of relative 
perfusion and, in that case, it is vulnerable to the balanced impairment of perfusion 
in 3-vessel disease, small vessel disease or in other myocardial diseases with a lack of 
myocardial perfusion.  
PET/CT hybrid scanners allow visualization of the coronary stenosis and 
quantification of myocardial perfusion in absolute terms. This improves the 
diagnostic accuracy in cases with balanced reduction of perfusion. Studies using 
PET/CT hybrid imaging have shown promising results in the detection of 
functionally significant CAD, improving the PPV of coronary CT scanners without 
worsening the NPV (Namdar et al., 2005). Similarly, in a recently published head-
to-head comparison, quantitative PET perfusion imaging showed the best diagnostic 
accuracy with FFR-defined stenosis (sensitivity 87% and specificity 84%) compared 
with SPECT/CT, and quantification was particularly useful in patients with 
multivessel disease (Danad et al., 2017). Reduced myocardial perfusion in PET has 
prognostic value and is a significant predictor of cardiac death and myocardial 
infarction (Ziadi et al., 2011; Dorbala et al., 2013, Maaniitty et al., 2017). 
The integration of PET and CT has made it feasible to assess coronary anatomy 
and perfusion in the same session and has made the diagnosis of significant CAD 
faster, more accurate and patient friendly. The quality of scanners has improved 
leading to better accuracy and PPV compared with CTA alone.  
Modern hybrid PET/CT scanners offer superb diagnostic tools for evaluating 
symptomatic patients with suspected CAD. Single measurement of absolute MBF is 
a valid method to diagnose hemodynamically significant coronary artery stenosis 
and allows a shorter imaging protocol and lower radiation dose than measurement 
of MFR. The meta-analysis from 2015 showed that stress myocardial perfusion 
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imaging with CT/PET can accurately rule out hemodynamically significant CAD 
and act as a gatekeeper for PCI (Takx et al., 2015). 
With modern TTDE devices, it has been able to visualize the coronary artery 
stenosis for over 20 years (Kenny et al., 1992; Saraste et al., 2000). Despite better 
devices and better image quality, the use of TTDE for coronary flow imaging, as well 
as the combination of coronary ultrasound with CT, is a less common method for 
diagnosing significant CAD. In hybrid imaging of TTDE/CT, CTA shows the 
anatomic changes and stenosis of coronary arteries; when combined with TTDE of 
coronary arteries, it is able to assess the functional significance of each stenosis. 
Therefore, the hybrid imaging of TTDE/CT results in better PPV when compared 
with CTA alone (Pizzuto et al., 2009). 
Table 1. The performance of different tests for anatomically and functionally significant coronary 
artery disease. 
 
 
(+LR = positive likelihood ratio, -LR = negative likelihood ratio, CI = confidence interval, CCTA = 
coronary computed tomography angiography, CMR = cardiac magnetic resonance) Referenced 
from Eur Heart J. 2018 Sep 14;39(35):3322-30. doi: 10.1093/eurheartj/ehy267 
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3 Aims of the Study 
The purpose of the study was to investigate hybrid imaging methods in the diagnosis 
of stable CAD in symptomatic patients with intermediate (30-70%) pretest 
likelihood of CAD. 
 
The detailed aims were as follows: 
 
1. To study the feasibility of hybrid PET/CT in the detection of obstructive CAD 
(Study I) 
2. To compare the accuracy of quantified myocardial flow reserve and absolute 
stress myocardial blood flow alone in the diagnosis of obstructive CAD (Study 
II) 
3. To study the feasibility and accuracy of sequential CTA and TTDE in the 
detection of hemodynamically significant CAD (Study III) 
  25 
4 Materials and Methods 
4.1 Study design 
The study comprises three substudies (I–III) that were performed during 2007 – 
2013. The aim of these studies was to investigate the accuracy and feasibility of hybrid 
imaging methods in patients with an intermediate pretest likelihood of CAD. 
Study I studied the feasibility and accuracy of hybrid PET/CT imaging to detect 
CAD in a symptomatic patient population. Study II compared absolute stress 
perfusion alone to perfusion reserve for detecting hemodynamically significant 
CAD. Study III evaluated the feasibility of sequential use of CTA and TTDE for a 
combined anatomic and functional evaluation of coronary stenosis; the combination 
of CTA/TTDE was compared with CTA alone. 
4.2 Subjects 
4.2.1 Study I 
The study population comprised 107 subjects with an intermediate pretest likelihood 
of CAD based on age, sex, symptoms and their exercise test results (Table 2). The 
exclusion criteria were atrial fibrillation, heart failure, severe renal dysfunction, 
unstable asthma, iodine allergy, second or third degree AV-block, unstable angina 
pectoris or pregnancy. Patients with a clinical history of myocardial infarction or 
angiographically proven CAD were ineligible. All patients went PET-CTA using a 
64-slice scanner with quantitative PET (¹O-water) and CT angiography. In Study I, 
the PET/CT results were compared with invasive angiography and FFR 
measurement when appropriate.  
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Table 2. Patient characteristics (Study I, n=107) 
Gender (M/F) 64/43 
Mean age (Y) 63.6 ± 7.0 (range, 49–80) 
Weight (kg) 77.9 ± 17.8 (range, 50–113) 
BMI 26.6 ± 3.9 (range, 18.4–39.1) 
Risk factors for CAD #positive 
Family history 48 (45%) 
Diabetes  15 (14%) 
Hypertension 44 (41%) 
Hypercholesterolemia 54 (50%) 
Smoking or ex-smoking 28 (26%) 
Exercise test 90 (84%) 
Medication  
Statins 54 (50%) 
Beta blockers 64 (60%) 
Aspirin 78 (73%) 
Long acting nitrates 10 (9%) 
(Reproduced with permission from Circulation. 2010 Aug 10;122(6):603–13. doi: 
10.1161/CIRCULATIONAHA.109.915009. Epub 2010 Jul 26) 
4.2.2 Study II 
In Study II, the study population was the same as in Studies I and III, but the 
complete PET images of three patients were unavailable and the patients were 
excluded. Thus, the final study population comprised 104 patients, whose 
characteristics are shown in Table 3. 
Table 3. Characteristics of study patients (Study II, n=104) 
Gender (male/female) 64/40 
Age (years) 64 (50–80) 
Weight (kg) 78 (50–116) 
Body mass index 26.6 (18.0–39.1) 
Risk factors:  
Family history of CAD 42 (40.4%) 
Diabetes 13 (13.0%) 
Impaired glucose tolerance 9 (8.7%) 
Hypertension 39 (37.5%) 
Hypercholesterolemia 53 (51.0%) 
Current or previous smoker 24 (23.1%) 
Medication:  
Statin 49 (48.5%) 
Beta blocker 56 (53.8%) 
Aspirin 70 (67.3%) 
Long acting nitrate 7 (6.7%) 
(Reproduced with permission from Eur Heart J Cardiovasc Imaging. 2014 Jun;15(6):659–65. doi: 
10.1093/ehjci/jet274. Epub 2014 Jan 9.) 
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4.2.3 Study III 
As part of a study I, we prospectively enrolled 107 patients with chest pain and 30–
70% pretest likelihood of CAD based on age, symptoms, sex, and the exercise test 
result. Exclusion criteria were the same as in Study I. Six patients were excluded from 
the study because of failure to perform TTDE prior to invasive coronary 
angiography. Table 4 summarizes the characteristics of the final study population 
comprising 101 patients.  
Table 4. Characteristics of study III patients. Reproduced with permission from Eur Heart J 
Cardiovasc Imaging. 2012 Jan; 13(1):79–85. doi: 10.1093/ejechocard/jer153. Epub 2011 Aug 30). 
Gender (male/female) 60/41 
Age (years) 64 (50–80) 
Weight (kg) 78 (50–116) 
Body mass index 26.6 (18.0–39.1) 
Risk factors:  
Family history of CAD 43 (42.6%) 
Diabetes 14 (13.9%) 
Impaired glucose tolerance 9 (8.9%) 
Hypertension 40 (39.6%) 
Hypercholesterolemia 56 (55.5%) 
Current or previous smoker 26 (25.7%) 
Medication:  
Statin 49 (48.5%) 
Beta blocker 58 (57.4%) 
Aspirin 72 (71.3%) 
Long acting nitrate  8 (7.9%) 
4.3 Methods 
4.3.1  Imaging protocols 
4.3.1.1 CT imaging 
Figure 2 demonstrates the imaging protocol in all studies (I-III). All patients were 
scanned with a 64-row PET/CT scanner (GE Discovery VCT, General Electric 
Medical Systems, WI, USA). If not contraindicated, 0-30 mg intravenous metoprolol 
was administered before the scan to reach the target heart rate (HR) of <60/min.  800 
μg of sublingual nitrate was given prior to the scan. An iodinated contrast infusion 
(60-80 ml of 400 mg I/ml iomeprolol at 4-4.5 ml/s) was followed by a saline flush. 
The collimation was 64x0.625 mm, gantry rotation time 350 ms, tube current 600-
750 mAs and voltage 100-120 kV, depending on patient size. Prospectively gated 
acquisition was applied whenever possible (86/107 patients) to reduce the radiation 
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dose. ECG-based tube current modulation was utilized to decrease the dose when 
the retrospectively gated mode was used (21 patients).  
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Figure 2. The combined PET/CT imaging protocol used in study I and II. (CTAC = CT-based 
attenuation correction) (Reproduced with permission from Circulation.2010Aug10;122(6):603–13. 
doi: 10.1161/CIRCULATIONAHA.109.915009. Epub 2010 Jul 26). 
4.3.1.2 PET imaging 
In Studies I and II, the rest-stress perfusion cardiac PET was performed immediately 
after CT angiography with a 64-row PET/CT scanner. Dynamic PET scans at rest 
and during pharmacologic stress were performed. 15O-labeled water (900-1100 MBq) 
was injected (Radiowater Generator, Hidex Oy, Turku, Finland) as an intravenous 
bolus over 15s at an infusion rate of 10 ml/min. A dynamic acquisition of 4 min 40 s 
was performed (14x5 s, 3x10 s, 3x20 s and 4x30 s). A stress scan was performed 
during adenosine-induced hyperaemia after a 10 min decay of the 15O radioactivity. 
Adenosine was started two minutes before the scan start and infused to the end of 
the scan at 140µg/kg body weight/min. Alignment of PET images and CT images 
used for attenuation correction was instantly adjusted and confirmed visually for all 
rest and stress studies after imaging. Images were reconstructed using 2D OSEM 
algorithm. 
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4.3.1.3 TTDE imaging 
Study III evaluated coronary artery segments with >20% stenosis in CTA using 
TTDE by cardiologists who were blinded to the severity of stenosis in CTA in a 
separate imaging session using Acuson Sequoia C512 ultrasound unit (Siemens 
Acuson, Mountain View, CA, USA) equipped with a standard 3.5-MHz transducer 
(3V2c). The expected anatomic course of the coronary artery segments of interest 
was studied using color Doppler mapping and all possible standard and non-
standard windows and views as previously described. The velocity scale of color 
Doppler was actively changed, but it was initially set to 0.24 m/s. The color box size 
was reduced to maintain the high frame rate. The left main coronary artery (LM) and 
proximal LAD were studied from the left parasternal short- and long-axis views 
focusing on the area adjacent to the sinus Valsalva (Figure 2). The origin of the first 
septal branch of the LAD marking the border between the proximal and the middle 
segments of the LAD could be visualized in most patients. The left parasternal 
windows, at varying levels using modified short- and long-axis views focusing on the 
anterior interventricular groove (LAD) or atrioventricular groove (LCX) were used 
to visualizethe middle and the distal LAD as well as the proximal LCX. The more 
distal parts of the LCX were studied using the apical long-axis view, focusing on the 
lateral mitral ring, and the four-chamber view, focusing on the inferior mitral ring. 
The ostium and the proximal RCA were seen from the left parasternal short-axis 
view in the area of the right sinus Valsalva. The part of the RCA passing the anterior 
surface of the tricuspid ring until the inferior margin of the right ventricle was 
considered as the proximal RCA, and the proximal and the middle RCA were 
searched from the right parasternal short- and long-axis views when the patients 
were lying on their right side, focusing on the anterior and medial tricuspid rings. 
The subcostal short-axis view, focusing on the medial tricuspid ring on the inferior 
surface of the heart, was also used. The distal RCA was visualized from the subcostal 
four- and two-chamber views, focusing on the posterior tricuspid ring. The right 
posterior descending branch of the RCA was visualized using a modified, apical two-
dimensional view.  
Possible coronary stenosis was identified in the segments of interest as localized 
color aliasing, indicating accelerated and turbulent flow, as described earlier and 
illustrated in Figure 3. Accelerated and turbulent flow at the site of stenosis causes a 
strong signal that facilitates its identification, whereas normal coronary flow is slow 
and laminar and causes only a weak Doppler signal. To assess severity of coronary 
stenosis by TTDE, we measured maximal flow velocity by pulsed-wave Doppler at 
the site of aliasing and prestenotic flow velocity in the nearest proximal, non-aliased 
point of the vessel to calculate the M/P ratio (Figure 3). Blood flow velocity was 
measured at the beginning of diastole, using a pulsed-wave Doppler with 2 MHz 
frequency in an average sample volume of 5 mm. Successive cardiac cycles were 
analyzed to find average flow velocity. The angle between flow and Doppler beam 
Esa Joutsiniemi 
 30
was kept as small as possible and used angle correction. In some coronary segments, 
because of the artery’s horizontal course, the angle between ultrasound beam and 
flow remained >60°. In these segments, stenotic flow velocity was approximated by 
the appearance of aliasing upon rescaling of the color Doppler Nyqvist limit. A pre-
defined cut-off value was used for the M/P ratio (2.2) for comparison of CTA alone 
vs. CTA and TTDE (Hozumi et al., 2000), in addition to testing the optimal cut-off 
value of the M/P ratio to detect significant stenosis in our patients.  
Flow in the septal branches of the LAD were also evaluated from left parasternal 
short-axis views using color Doppler to detect total LAD and RCA occlusions, as 
described previously (Saraste et al., 2005; Otsuka et al., 2005; Watanabe et al., 2001). 
Chronic occlusion results in heightened collateral flow through septal branches that 
causes flow acceleration and makes long, continuous segments of flow signals visible 
by TTDE. In patients with non-detectable flow in either the LAD or the RCA, 
reversed heightened flow from right to left in the septal branches of the LAD were 
considered as a marker of total occlusion in the LAD, whereas heightened Doppler 
signals in the normal direction were considered as a sign of total occlusion in the 
RCA. 
 
Figure 3. Analysis of coronary stenosis by sequential computed tomography angiography and 
transthoracic Doppler echocardiography.  
(A) Computed tomography angiography image of >50% stenosis in the proximal left 
anterior descending (LAD; arrow). Transthoracic Doppler echocardiography 
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demonstrates accelerated coronary flow at the site of stenosis seen as local aliasing 
(arrow) in a modified parasternal short-axis color Doppler image when Nyqvist limit 
is set to 0.2 m/s (B). Pulsed-wave Doppler recording at the site of aliasing 
demonstrates maximal diastolic flow velocity of 2.4 m/s (arrow in C), whereas 
prestenotic flow velocity is 0.24 m/s (arrow in D) resulting in the M/P ratio of 10. 
Invasive coronary angiography demonstrated significant stenosis causing luminal 
narrowing of 73% (arrow in E). (Reproduced with permission from Eur Heart J 
Cardiovasc Imaging. 2012 Jan;13(1):79-85. doi: 10.1093/ejechocard/jer153. Epub 2011 
Aug 30). 
4.3.1.4 Invasive angiography and FFR 
All coronary angiographies were performed on the Siemens Axiom Artis coronary 
angiography system (Siemens, Munich, Germany). FFR measurement was 
performed on stenosis > 30%, when feasible, using ComboMap® pressure/flow 
instrument and a 0.014-inch BrightWire® pressure guidewires (Volcano Corp., 
Rancho Cordova, CA, USA). Hemodynamically significant stenosis was detected 
based on FFR value <0.8 in 14/23 of these vessels. FFR was calculated as the ratio 
between mean distal pressure and mean aortic pressure; the pressure was measured 
distally to the lesion during maximal hyperemia induced by 18 µg intracoronary 
boluses of adenosine with simultaneous measurement of aortic pressure through the 
coronary catheter.  
4.3.2 Data analysis 
4.3.2.1 CT analysis 
An experienced cardiologist and radiologist analyzed the vessels separately and then 
in concord on an ADW 4.4 Workstation (General Electric, Milwaukee, WI., USA) 
blinded to other results and clinical data, using a standard 17 vessel segment system 
adapted from the original AHA model. 
4.3.2.2 PET analysis 
Studies I and II quantitatively analyzed the PET images using validated CarimasTM 
software; an experienced observer analyzed the images blinded to other results and 
clinical data as studied earlier (Nesterov et al., 2009). The definition of regions of 
interest (ROI) in the myocardium and blood pool inside the left ventricular cavity 
was performed automatically but was usually accompanied by visual confirmation 
and appropriate manual adjustment. Volume view and reorientation were done 
manually, but modelling and reporting of results were automatic. The 
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reproducibility of the analysis has been reported by Nesterov et al. (2009).  Average 
MBF values were measured for regions of the RCA, LAD and LCX, using individual 
known coronary anatomy both at rest and during stress. The 312 region was 
altogether analyzed. Average MFR was calculated in each region as the ratio of stress-
to-rest MBF. The absolute increase was calculated as the absolute difference between 
stress and rest MBF. Optimal threshold values of MFR, absolute increase of MBF and 
absolute stress MBF for detecting significant coronary stenosis were defined by ROC 
analysis. We also tested 2.0 as the predefined cut-off value of MFR (Uren et al., 1994) 
and 2.4ml/g/min as the predefined cut-off value of absolute stress MBF (Nesterov et 
al., 2009). Stenosis in the LM coronary artery was considered to affect perfusion in 
both the LAD and LCX areas. 
4.3.2.3 TTDE analysis 
Coefficient of variation for repeated measurements of the M/P ratio by the same or 
two independent observers in 10 stenoses varying from 30 to 95% (2, 6 and 2 in the 
RCA, LAD, LCX, respectively) in four patients were 5 and 6%, respectively. 
4.3.2.4 ICA analysis 
Quantitative analysis of coronary angiograms (QCA) was performed using software 
with an automated edge detection system (Quantcore, Siemens, Munich, Germany) 
by an experienced cardiologist blinded to the results of PET, CTA and FFR. 
Significant stenosis was defined as luminal diameter narrowing >50% by QCA. 
Regardless of the degree of narrowing, stenosis with FFR ≥0.8 was classified as non-
significant when FFR was available.  
4.3.3 Statistical methods 
4.3.3.1 Study I 
Sensitivity, specificity, PPV, NPV, and accuracy were calculated for each imaging 
method (CT, PET and PET/CT). An ROC analysis curve was used to reconfirm the 
best cutoff points of MBF stress in the current population. The McNemar test was 
performed to compare the accuracy of CT, PET, and PET/CT against the gold 
standard (i.e., ICA with FFR). A value of P<0.05 was considered statistically 
significant. Statistical tests were performed with SAS version 9.1 (SAS Institute Inc, 
Cary, NC). 
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4.3.3.2 Study II 
Accuracy, sensitivity, specificity, PPV and NPV were calculated for each imaging 
method (CT, PET, and PET/CT). A ROC analysis curve was used to reconfirm the 
best cut-off points of MBF stress, MFR, and the absolute increase of MBF at stress in 
the current population. Area under the curve (AUC) values were compared using 
the Chi-square test. McNemar’s test was performed to compare the accuracy of stress 
MBF, increase of MBF and MFR cut-offs <2.0 and <2.5 against the gold standard 
(i.e., ICA with FFR). The effect of beta-blocker therapy was tested using Fisher's exact 
test. The analyses were performed both per main vessel and per patient (correctly 
classified as either with or without significant coronary artery stenosis). A P-value of 
<0.05 was considered statistically significant. The statistical tests were performed 
with SAS version 9.1 (SAS Institute Inc, Cary, NC). 
4.3.3.3 Study III 
Continuous variables are expressed as the mean ± SD and compared between two 
groups by independent sample t-test. Receiver operating characteristic (ROC) 
analysis was used to find the optimal cut-off point of the M/P ratio. Sensitivity, 
specificity, PPV, NPV, and accuracy were calculated for CTA alone and in 
combination with focused TTDE (in all lesions that were evaluated by TTDE, 
stenosis was classified according to TTDE findings) on patient and segment levels. 
McNemar's test was performed to compare accuracy, sensitivity, and specificity of 
the strategy of CTA alone and in combination with focused TTDE. A P-value of 
<0.05 was considered as statistically significant. 
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5 Results 
5.1 Cardiac positron emission tomography/ 
computed tomography imaging accurately 
detects anatomically and functionally 
significant coronary artery disease (Study I) 
5.1.1 Patent characteristics 
For the study we enrolled 107 patients without previous myocardial infarction with 
30-70% pretest likelihood of CAD.  
All patients underwent coronary CTA. Myocardial PET perfusion was 
successfully made to 104 patients with PET/CT hybrid scanner, and ICA was made 
within two weeks. The FFR measurements were performed in > 30% stenoses when 
feasible. When coronary artery was either totally occluded or stenosis was > 90% and 
FFR was not performed, the clinical information of ICA and quantitative analysis of 
coronary angiogram (QCA) was considered positive and vessel graded accordingly. 
Forty-four patients of 107 (41%) had ≥ 50% stenosis in their coronary arteries in 
ICA, and after FFR, stenosis was graded significant in 40 patients. In 18 patients out 
of 40, the stenosis was either total occlusion or > 90% stenosis, such that FFR was not 
performed. Four other patients had intermediate stenosis in which FFR could not be 
performed due to logistic or technical reasons. Patients without FFR and stenosis ≥ 
50% by QCA were considered as having a significant stenosis. By the combination of 
ICA, QCA and FFR, 80 of 428 arteries were significantly stenosed. 
5.1.2 CT Angiography 
CTA alone had a PPV of 81%, an NPV of 97%, and an accuracy of 90% per patient. 
In per vessel analyses PPV, NPV and accuracy were 76%, 94%, and 91%, respectively. 
In most false cases, CT overestimated the degree of stenosis. There were only two 
patients in whom CAD was missed, but in 10 patients, at least one significantly 
stenosed coronary artery was not detected. These lesions were evenly distributed into 
different coronary branches. 
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5.1.3 PET Perfusion Imaging 
Perfusion at rest was normal in all patients. The stress perfusion in patient-based 
analysis had a PPV, an NPV, and an accuracy of 86%, 97%, and 92%, respectively. 
The corresponding values in per vessel analysis were 78%, 98%, and 92%. Potentially 
false-negative PET perfusion results occurred in two patients. They had ≥50% 
stenosis detected at ICA, but FFR could not be performed. Six patients had false-
positive PET perfusion; five of them had diffusely reduced myocardial perfusion but 
no epicardial CAD. A regional perfusion defect was incorrectly diagnosed in one 
patient. In per vessel analysis, four other patients exhibited at least one perfusion 
abnormality in a region without significant epicardial CAD. 
5.1.4 Hybrid Imaging 
Most patients with false-positive CT angiography had normal PET perfusion, which 
corrects the diagnoses. Four out of five patients with false-positive PET findings had 
diffusely abnormal perfusion, but no epicardial CAD in CT; these cases were 
correctly identified in hybrid imaging. In one case, there was diffusely reduced 
perfusion, but one stenosed vessel. Table 5 shows the characteristics of the five 
patients with suspected microvascular disease (i.e., those with diffusely reduced 
perfusion without accompanying epicardial CAD). Furthermore, CTA vessel 
analysis helped to assign the perfusion zones of the LCX and the RCA, because the 
dominant vessel is easily distinguished. In combined analysis, only one false-negative 
and no false-positives were diagnosed. PPV, NPV, and accuracy were 100%, 97%, 
and 98%, respectively. 
Table 5. Patients with diffuse perfusion abnormalities but non-stenotic epicardial coronary arteries 
Patient gender smoker 
Body Mass 
Index Diabetes 
Family history 
of CAD 
PET stress 
MBF 
(ml/g/min) 
Agatston 
score 
P006 male no 21.8 no no 1.7–2.1 117 
P010 male yes 33.1 no yes 1.2–2.3 6 
P077 male no 19.4 no yes 1.4–1.8 16 
P079 female no 19.1 no yes 1.6–2.0 0 
P090 male yes 25.7 no yes 1.7–1.8 0 
(Reproduced with permission from Circulation. 2010 Aug 10;122(6):603–13. doi: 10.1161/ 
CIRCULATIONAHA.109.915009. Epub 2010 Jul 26). 
PPV, NPV, and accuracy of per vessel analysis were 96%, 99%, and 98%, respectively. 
In three vessels with intermediate (30% to 70%) stenosis in CTA, hybrid imaging was 
abnormal but invasive tests identified non-significant lesions. Hybrid imaging 
suggested non-significant lesions in five other vessels, but ICA showed ≥ 50% 
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stenosis. All of these vessels, however, were classified according to ICA alone because 
of a lack of FFR. Table 6 summarizes the discrepant findings between hybrid imaging 
and the gold standard. 
Hybrid imaging was more accurate per patient than CTA (P = 0.0039) or PET 
alone (P = 0.014) and was better in the per vessel analysis (P < 0.0001 and P < 0.0001, 
correspondingly). Figures 4 and 5 present ROC tables that are in agreement with 
earlier cutoff values (Nesterov et al., 2009). An MBF value of 2.5 ml/g/min gives the 
best combination of sensitivity and specificity when analyzed both with and without 
CTA information. The estimated probability of CAD based on ROC analysis 
(Figures 6 and 7) demonstrated that practically all regions with MBF < 2.0 ml/g/min 
were abnormal. 
Table 6. Discrepant findings between combined CTA and PET against gold standard 
Patient Vessel 
CTA 
stenosis 
PET stress MBF 
(ml/g/min) 
Invasive 
stenosis 
(QCA) 
Suspected explanation for 
discrepancy  
P020 LAD 50–69% 3.1 (normal) 55 % Mid LAD intermediate stenosis, no successful FFR 
  RCA 50–69% 2.1 (abnormal) 39 % Two stenoses distally in RCA, no FFR. 
P031 RCA 50–69% 2.0 (abnormal) 40 % 
Severe calcifications in CTA and 
reduced flow, in ICA intermediate 
stenosis in mid RCA, no FFR 
P033 LAD >70% 3.0 (normal) 50–60% Proximal and mid LAD intermediate stenoses, no successful FFR 
P034 RCA 30–49% 0.8 (abnormal) 30–49% Long but mild wall irregularities in distal RCA, no successful FFR 
P070 LAD 50–69% 3.1 (normal) 50 % Mid LAD intermediate stenosis, FFR was not successful 
P084 RCA 50–69% 1.9 (abnormal) 39 % Distal RCA intermediate stenosis, no FFR 
(Reproduced with permission from Circulation. 2010 Aug 10;122(6):603–13. doi: 
10.1161/CIRCULATIONAHA.109.915009. Epub 2010 Jul 26). 
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Figure 4. ROC curve of vessel-based PET perfusion against gold standard (ICA + FFR) with cut-
off values (without CTA information). 
 
Figure 5. ROC curve of PET perfusion against gold standard with cut-off values (with CTA 
information). (Reproduced with permission from Circulation. 2010 Aug 10;122(6):603–13. doi: 
10.1161/CIRCULATIONAHA.109.915009. Epub 2010 Jul 26). 
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Figure 6. Estimated probability of significant CAD against stress MBF. 
 
Figure 7. Estimated probability of significant CAD against stress MBF (with significant stenosis in 
CTA). (Reproduced with permission from Circulation. 2010 Aug 10;122(6):603–13. doi: 
10.1161/CIRCULATIONAHA.109.915009. Epub 2010 Jul 26). 
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5.2 Comparing of absolute flow vs myocardial flow 
reserve in significant CAD (Study II)  
Study II analyzed the original PET perfusion data by comparing myocardial 
quantitative blood flow (MBF) during adenosine stress to myocardial flow reserve 
(MFR). Also the absolute increase of MBF from rest to stress was measured and 
compared with MFR. The effect of beta-blocker therapy was also considered in its 
own analysis. 
5.2.1 Threshold values of absolute MBF and MFR for 
detection of stenosis 
In the analysis the average rest MBF was comparable in the myocardial regions 
subtended by significantly stenosed coronary arteries and non-stenosed arteries 
(0.96 ± 0.27 vs. 1.0 ± 0.25 mL/g/min, P = 0.04), but absolute MBF during adenosine 
stress was significantly lower in the regions subtended by significantly stenosed 
coronary arteries (1.77 ± 0.59 vs. 3.53 ± 1.0 mL/g/min, P < 0.0001). The absolute 
increase of MBF was significantly lower in the stenosed regions than in non-stenosed 
regions (0.81 ± 0.59 vs. 2.49 ± 0.95 mL/g/min, P < 0.0001). Thus, average MFR was 
lower in the presence of hemodynamically significant stenosis than in the absence of 
stenosis (1.94 ± 0.79 vs. 3.5 ± 1.0, P < 0.001). Figure 8 shows example polar maps of 
absolute MBF at rest and stress in a patient with significant coronary stenosis. 
 
Figure 8. Examples of polar maps of MBF as assessed by ¹O-water PET and analysed using the 
CARIMAS™ -software at rest (a) and during adenosine stress (b). Reproduced with permission 
from Eur Heart J Cardiovasc Imaging. 2014 Jun; 15(6):659–65.doi: 10.1093/ehjci/jet274. Epub 
2014 Jan 9. 
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Figure 9 shows the ROC curves of MFR, rest MBF alone, stress MBF alone, and an 
increase of MBF from rest to stress for detection of significant coronary stenosis. The 
optimal cut-off value for detecting significant coronary stenosis was: absolute stress 
(AUC: 0.95) MBF was 2.4 mL/g/min, absolute increase of MBF from rest to stress 
was 1.5 mL/g/min (AUC: 0.95) and MFR 2.5 (AUC: 0.90). 
 
Figure 9. The ROC curves comparing diagnostic accuracy of MFR (green, dotted line), stress MBF 
alone (blue, continuous line), absolute increase of MBF from rest to stress (brown, cut line), and 
rest MBF alone (red, cut line) for detection significant coronary stenosis. Reproduced with 
permission from Eur Heart J Cardiovasc Imaging. 2014 Jun;15(6):659–65. doi: 
10.1093/ehjci/jet274. Epub 2014 Jan 9. 
5.2.2 Comparison of diagnostic accuracy 
In ROC curve analysis (Figure 9), absolute stress MBF alone performed better than 
MFR in the detection of significant coronary stenosis (area under the ROC curve 
0.95 vs. 0.90, P = 0.02). The performance of absolute stress MBF and increase of MBF 
(area under the ROC curve 0.95) was comparable (P = 0.52). 
Table 7 shows the diagnostic accuracies for detecting significant stenosis in the 
whole patient group (vessel- and patient-based) with MFR, absolute stress MBF 
alone, and absolute increase of MBF from rest to stress. Sensitivity of absolute 
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increase of MBF from rest to stress by adenosine was better than that of MFR with 
2.5 cut-off (P = 0.003), while specificity remained comparable (P = 0.08). Similarly, 
stress MBF alone resulted in better sensitivity (P = 0.035) than MFR with cut-off 2.5 
without compromising specificity (P = 0.27). The stress MBF alone had better 
accuracy than MFR with cut-off 2.5 (P = 0.04), whereas absolute increase of MBF 
and MFR had comparable accuracy.  
Table 7 shows that on patient-based analysis, diagnostic accuracies, sensitivities 
and specificities of MFR, stress MBF alone, and absolute increase of MBF from rest 
to stress, were comparable. The number of patients with all regions correctly 
classified by stress MBF alone was 88 (accuracy 84%) and MFR 75 (accuracy 74%). 
Table 7. Diagnostic accuracy of myocardial flow reserve (stress MFR <2.5), absolute stress 
myocardial blood flow (MBF) and absolute increase of (increase MBF) for the detection of significant 
stenosis in the whole patient group. Reproduced with permission from Eur Heart J Cardiovasc 
Imaging. 2014 Jun;15(6):659–65. doi: 10.1093/ehjci/jet274. Epub 2014 Jan 9. 
 Vessel-based analysis (n=312) 
 accuracy sensitivity specificity PPV NPV 
MFR 86 80 87 66 93 
Stress MBF 90* 89* 90 73 96 
Increase MBF 88 92 87 69 97 
 Patient-based analysis (n=104) 
 accuracy sensitivity specificity PPV NPV 
MFR 88 87 88 80 92 
Stress MBF 91 95 89 84 97 
Increase MBF 89 95 86 80 97 
PPV=positive predicive value, NPV=negative predictive value, *:p<0.05 vs. MFR 
We compared diagnostic accuracies of MFR with the cut-off value of 2.5 or 2.0. On 
vessel-based analysis, the accuracy, sensitivity, specificity, PPV, NPV, and of MFR 
with cut-off value of 2.0 were 87, 57, 95, 84, and 88% (for both sensitivity and 
specificity P < 0.0001 vs. 2.5 cut-off), respectively. The corresponding values on 
patient-based analysis were 85, 66, 95, 89 (P = 0.005 vs. 2.5 cut-off), and 83% (P = 
0.03 vs. 2.5 cut-off). Table 6 shows the results with MFR cut-off value of 2.5. 
5.2.3 Effect of beta-blocker therapy 
Because of i.v. beta-blocker usage before CT angiography and the PET scans, 
diagnostic accuracy of MFR and absolute stress MBF were studied separately in 
patients who received (n = 79) or did not receive (n = 25) i.v. beta-blocker therapy 
prior to perfusion imaging. In the regions that were subtended by non-stenosed 
coronary arteries, rest MBF was comparable in patients who received or did not 
receive beta-blocker prior to imaging (1.0 ± 0.2 vs. 1.0 ± 0.3 mL/min/g, P = 0.60). 
MFR was not different (3.5 ± 1.0 vs. 3.1 ± 0.9 mL/min/g, P = 0.10), though stress 
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MBF was slightly higher in patients who received beta-blocker (3.5 ± 1.0 vs. 3.0 ± 0.9 
mL/min/g, P = 0.04). 
Table 8 shows that the diagnostic accuracy of MFR, absolute stress flow, and 
absolute increase of MBF during adenosine stress were comparable in patients who 
received or did not receive beta-blocker therapy. 
Table 8. Diagnostic accuracy of myocardial flow reserve (stress MFR), absolute stress myocardial 
blood flow (MBF) and absolute increase of (increase MBF) for the detection of significant stenosis 
in patients who received or did not receive intravenous beta-blocker prior to imaging (vessel-based 
analysis). Reproduced with permission from Eur Heart J Cardiovasc Imaging. 2014 Jun;15(6):659–
65. doi: 10.1093/ehjci/jet274. Epub 2014 Jan 9. 
 beta-blocker (n=237) 
 accuracy sensitivity specificity PPV NPV 
MFR 87 83 88 63 95 
Stress MBF 91 96 90 69 99 
Increase MBF 88 91 87 64 98 
 no beta-blocker (n=75) 
 accuracy sensitivity specificity PPV NPV 
MFR 80 78 81 70 87 
Stress MBF 91 93 90 83 96 
Increase MBF 88 93 85 78 95 
PPV=positive predicive value, NPV=negative predictive value.  
5.3 Resting coronary flow velocity in the functional 
evaluation of coronary artery stenosis (Study III) 
5.3.1 Patients 
Study III measured the ratio of maximal diastolic flow velocity to prestenotic flow 
velocity (M/P ratio) in the coronary segments with stenosis in CTA in patient 
population described 4.2.3. 
5.3.2 Invasive coronary angiography (ICA) 
There were no cardiac events between CTA and ICA. In invasive coronary 
angiography, 34 (34%) patients out of 101 had stenosis ≥ 50% in their coronary 
arteries. Hemodynamically significant lesions after invasive angiography and FFR 
were detected in 33 patients. In 14 of them, the lesions were either total occlusions 
or extremely tight (> 90%) stenosis in which FFR was not possible. Four other 
patients had 30 – 70% stenosis in which FFR could not be performed due to 
scheduling or technical reasons. In patients with no FFR performed, > 50% stenosis 
by QCA was considered positive and the vessel graded accordingly. Altogether, there 
were 66 significant coronary artery stenoses; 39 in the LAD, 12 in the LCX, and 14 
in the RCA. Only one patient had significant LM disease. Among these stenoses were 
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six total occlusions (three in the mid LAD and three in the mid RCA). There were 
two subsequent stenoses in 10 vessels (8 LAD, 1 LCX, and 1 RCA). Fifteen patients 
had single-vessel disease, 10 had two-vessel disease, and eight had multivessel 
disease.  
5.3.3 Feasibility of TTDE 
Figure 3, (page 30) shows the assessment of a coronary stenosis with the use of TTDE 
together with corresponding CTA and invasive coronary angiography. Based on 
CTA, 285 lesions causing luminal narrowing of > 20% in 670 segments in 76 patients 
were evaluated with TTDE. There were 224 lesions (83% of the evaluated segments 
without total occlusion) in which the M/P ratios were quantified using the pulsed-
wave Doppler recordings of flow velocity profiles. In 52 segments, either TTDE 
indicated the total occlusion or the M/P ratio was approximated based on color 
Doppler signal due to inability to align ultrasound beam with the flow. There were 
eight segments in the RCA and one in the LAD in which the area of interest could 
not be visualized by TTDE (3% of segments). 
The average M/P ratio was higher in coronary segments with hemodynamically 
significant than non-significant stenosis (3.59 ± 1.82 vs. 1.28 ± 0.60 m/s, P < 0.001, 
Figure 10). The optimal cut-off value of the M/P ratio based on ROC curve analysis 
for discriminating non-significant and significant stenosis was 2.2 (AUC = 0.92 ± 
0.02, sensitivity 82%, specificity 94%, n = 224 stenosis, P < 0.001, Figure 11). 
 
Figure 10. Validation of the M/P-ratio in 224 coronary lesions evaluated by TTDE; the average M/P-
ratio was significantly higher in significant (n=53) than non-significant (n=169) stenosis. Modified 
from Eur Heart J Cardiovasc Imaging. 2012 Jan; 13(1):79–85. doi: 10.1093/ejechocard/jer153. 
Epub 2011 Aug 30). 
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Figure 11. Based on the receiver operating characteristic curve analysis, the optimal cut-off value 
for the detection of significant stenosis was 2.2 (AUC 0.92) providing good diagnostic accuracy (P 
< 0.001). Reproduced with permission from Eur Heart J Cardiovasc Imaging. 2012 Jan; 13(1):79–
85. doi: 10.1093/ejechocard/jer153. Epub 2011 Aug 30). 
Based on the evaluation of flow in the septal branches of LAD, TTDE correctly 
diagnosed two total occlusions in both the RCA and the LAD. One total occlusion in 
both vessels was missed. 
5.3.4 Sequential computed tomography angiography and 
transthoracic Doppler echocardiography vs. computed 
tomography angiography alone 
Coronary CTA alone showed high diagnostic accuracy for detecting significant 
stenosis or total occlusion on both a patient level (accuracy 90%, sensitivity 91%, 
specificity 89%, PPV 82%, and NPV 95%, n = 101) and a segment level (accuracy 
93%, sensitivity 71%, specificity 95%, PPV 61%, and NPV 97%, n = 670) as Figures 
12A and 12B shows. False findings were those with the detected stenosis 
overestimated by CTA resulting in a reduction in PPV. 
Subsequent CTA and TTDE provided higher PPV (78%) and better diagnostic 
accuracy on a segment level than CTA alone (accuracy 96%, p = 0.006) without 
impairment of NPV (97%; Table 9, Figure 12A). The false negative results (8 in the 
LAD, 3 in the LCX, and 3 in RCA) included two total occlusions, two subtotal (> 
95%) stenosis, seven stenoses that were 65 – 90%, and seven stenoses that were 50 – 
65% by QCA. The specificity of subsequent CTA and TTDE for significant stenosis 
was better (98%, *P = 0.004), whereas sensitivity was comparable (77%, P = 0.39) 
with CTA alone. 
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Figure 12A. Diagnostic performance of CTA alone (white bars) and in combination with TTDE (grey 
bars) (segment level). Reproduced with permission from Eur Heart J Cardiovasc Imaging. 2012 
Jan; 13(1):79–85. doi: 10.1093/ejechocard/jer153. Epub 2011 Aug 30). 
 
Figure 12B. Diagnostic performance of CTA alone (white bars) and in combination with TTDE (grey 
bars) (patient level). Reproduced with permission from Eur Heart J Cardiovasc Imaging. 2012 Jan; 
13(1):79–85. doi: 10.1093/ejechocard/jer153. Epub 2011 Aug 30). 
On a patient level, consecutive CTA and TTDE had accuracy of 93% (P = 0.07 vs. 
CTA alone), sensitivity of 91% (P = 1.0 vs. CTA alone), specificity of 95% (P** = 0.21 
vs. CTA alone), PPV of 91%, and NPV of 95% (Figure 12B). 
Seventy-five stenoses were classified as > 50% by CTA alone. In these segments, 
accuracy, sensitivity, specificity, PPV, and NPV of TTDE were 79, 80, 77, 84, and 
72%, respectively. The nine false negative results (6 in the LAD, 1 in the LCX, and 2 
in the RCA) included two total occlusions, two subtotal stenosis (> 95%), and two 
intermediate stenoses between 50 and 65% by QCA. Thirty-eight stenoses were 
measured as 50 – 70% by CTA alone. In these segments, accuracy, sensitivity, 
specificity, PPV, and NPV of TTDE were 82, 86, 75, 83, and 80%, respectively. TTDE 
correctly identified 15 of 20 stenoses in the vessels with two consecutive stenoses. 
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Table 9. Diagnostic performance of sequential CCTA and TTDE for the detection of significant 
stenosis. Reproduced with permission from Eur Heart J Cardiovasc Imaging. 2012 Jan; 13(1):79–
85. doi: 10.1093/ejechocard/jer153. Epub 2011 Aug 30). 
 stenosis (n) sensitivity (%) specificity (%) PPV (%) NPV (%) 
All* 66/670 77 98 78 97 
LAD 39/218 82 96 82 96 
LCX 12/151 67 99 89 97 
RCA 14/214 79 98 69 98 
*=LM+LAD+LCX+RCA (there was only one diseased LM) 
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6 Discussion 
6.1 Studies I, II and III 
Study I compared hybrid PET/CT imaging with individual imaging modalities in the 
detection of flow-limiting CAD. It demonstrated superiority of PET/CT hybrid 
imaging and had several unique features. 1) The first study to take full advantage of 
CT angiography and PET perfusion was performed with a hybrid imaging device, 
including quantitative perfusion analysis. 2) The study was performed in 
symptomatic patients with intermediate pretest likelihood of CAD as part of a 
routine clinical diagnostic work-up. 3) The patients underwent ICA blinded to the 
non-invasive test results to avoid referral bias. 4) The CTA and CT/PET results were 
compared to the combination of ICA and FFR, providing anatomic and functional 
results of circulation and perfusion of heart for comparisons.  
Study I shows that hybrid PET/CT is an excellent non-invasive, diagnostic 
method to rule out and diagnose hemodynamically significant CAD and to assess its 
severity. The imaging protocol is also short with a low radiation dose. The CTA alone 
had very good NPV (97% per patient and 94% per vessel) but only modest PPV 
compared with ICA, and with CTA it was very difficult to accurately evaluate the 
severity of stenosis. Even with a certain degree of stenosis, it is very difficult to 
estimate its functional significance to the myocardial perfusion, a common handicap 
in all anatomic imaging. Because normal PET perfusion rules out hemodynamically 
significant CAD (NPV 97% per patient and 98% per vessel), we can use PET 
perfusion imaging by itself to exclude occluding CAD. Reduced perfusion can also 
be a sign of microvascular disease, not only epicardial coronary artery disease. These 
changes can also increase the risk of cardiac events and death (Herzog et al., 2009) 
but are difficult to diagnose with common anatomic imaging methods. The PPV 
result of 86% (per patient in PET) suggests that small-vessel disease was also 
contributing to the findings. 
Myocardial flow reserve (MFR), i.e., ratio of stress and rest flow, has been 
commonly used to detect hemodynamically significant CAD with many imaging 
modalities, but we used absolute quantification of perfusion in PET in this study. 
Although absolute quantification has been validated in many studies with other 
tracers (Muzik et al., 1998; Yoshinaga et al., 2003; Parkash et al., 2004), it has rarely 
been used in clinical studies. Our study used ¹O-water, which has not commonly 
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used because it requires an on-site cyclotron. The advantage of ¹O-water is the linear 
uptake depending on the perfusion flow. Our ROC curve shows that the cut-off 
between normal and pathological MBF is < 2.5 ml/g/min, and practically all regions 
with MBF < 2.0 ml/g/min were abnormal. MBF values between 2.0 – 2.5 ml/g/min 
are considered mildly abnormal and clinical decisions are made by cardiologist 
depending on patient symptoms and other findings. Absolute quantification allows 
accurate detection of each myocardial region individually without relative changes 
in perfusion distribution, leading to better PPV and also more reliable diagnosis of 
CAD in multivessel and small-vessel diseases (Kajander et al., 2011; Ziadi et al., 2012; 
Fiechter et al., 2012; Naya et al., 2014). 
Performing CTA and PET perfusion imaging separately makes it possible to take 
advantages of both of these techniques. We avoid PET imaging when CTA is normal 
in everyday clinical use, but in this novel study, we needed to get information about 
the plaques that are not flow-limiting. It is valuable to diagnose CAD changes even 
if myocardial perfusion is not impaired. This will help us to advise our patient about 
correct preventive actions (i.e. start preventive medications or advice lifestyle 
modification) (Newby et al., 2015; Fordyce et al., 2016). The hybrid PET/CT 
perfusion imaging successfully combines both anatomical and functional imaging 
techniques. When CTA detects the degree and location of stenosis in a coronary 
artery and in that way separates microvascular from epicardial disease, the PET 
perfusion shows whether the findings are flow-limiting or not. In this study, the 
accuracy of the PET/CT hybrid imaging was superior. Also, the recent meta-analysis 
of hybrid cardiac imaging demonstrated improved diagnostic specificity of 
obstructive CAD when compared with stand-alone coronary CTA, without lowering 
sensitivity (Rizvi et al., 2018). 
Study II continued our research on the clinical value of absolute quantification 
of MBF with the same patient population as Study I’s. Because quantitative analysis 
has been shown to improve diagnostic accuracy and provide prognostic information 
(Muzik et al., 1998, Haijjiri et al., 2009) when compared with traditional myocardial 
flow reserve measurements, we wanted to study if stress MBF alone could be accurate 
and sufficient to detect CAD in patients without previous myocardial infarction. By 
measuring the MBF alone, we simplify and shorten the imaging protocols and reduce 
the radiation dose to the patient. The hypothesis that quantification of MBF during 
stress alone is reliable for diagnosing the CAD had not been prospectively validated 
in the clinical setting before this study. 
Study II is a prospective study to show that absolute stress MBF alone is sufficient 
to diagnose CAD in a relatively large number of patients. This study provides the 
first data showing that the stress MBF actually performs better than MFR in CAD 
detection. There are several factors that can explain the superiority of MBF over 
MFR. First, the reduced MFR may be caused by changes in resting flow, not 
necessarily changes in stress flow. Hypertension, hypertrophic cardiomyopathy and 
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dilated cardiomyopathy are examples of states that can increase cardiac workload at 
rest and may cause distortion to the measurements and diagnosis (Neglia et al., 2002; 
Cecchi et al., 2003). Second, the quantification of MBF involves dynamic and 
complex data acquisition and processing and, therefore, a single measurement is less 
affected by statistical noise. It is important, however, to realize that neither stress 
MBF nor MFR can differentiate whether reduced maximal flow is caused by 
microvascular dysfunction or epicardial coronary stenosis. This is not a problem 
when using a hybrid PET/CT scanner like we used in Study I, whereas in MBF 
analysis the reduced perfusion is diagnosed even when in relative MFR analysis these 
patients are classified as normal.   
The optimal threshold value of stress MBF for detecting >50% flow-limiting 
coronary stenosis was 2.4 ml/g/min in this study, which was in line with previous 
PET studies with ¹O-water. In MFR analysis the value < 2.0 is usually considered 
abnormal, but in our study the optimal threshold for detection of significant 
coronary stenosis was 2.5 instead of 2.0, leading to a better specificity without 
reducing sensitivity. Figure 9 (page 40) presents the ROC curve analysis comparing 
the diagnostic accuracy of MFR, stress MBF alone, absolute increase of MBF from 
rest to stress, and rest MBF alone for hemodynamically significant coronary artery 
stenosis. 
As Study I reported, the imaging protocol included coronary CT angiography in 
the same imaging session as the PET perfusion study. Therefore, beta-blocking 
therapy was used in most of the patients (79 out of 104) to reduce heart rate < 60 
bpm before imaging. We separately analyzed MBF for patients with and without 
beta-blocking therapy and found no difference in diagnostic accuracy between these 
two groups. It has been also previously demonstrated that beta blockers do not affect 
invasive measurements of FFR (Ozdemir et al., 2007). 
Study III demonstrated that the combination of CTA and TTDE is a potential 
method for anatomical and functional evaluation of CAD. Previous studies have 
demonstrated good sensitivity (64 – 86%) and specificity (92 – 96%) for diagnosing 
flow-limiting LAD stenosis in CAD but only limited feasibility when analyzing RCA 
(17 – 62%) or LCX (37 – 38%) (Krzanowski et al., 2000; Saraste et al., 2005; Caiati et 
al., 2009). This study was the first demonstration of a combined use of CTA and 
TTDE that can improve the success rate, since CTA allows focused analysis of TTDE. 
Relative increase in resting flow velocity by TTDE can discriminate flow-limiting 
stenosis from non-significant coronary lesions, defined by invasive coronary 
angiography and FFR. 
When measuring the coronary flow with TTDE, the turbulent and accelerated 
flow in-site of stenosis causes a strong color signal that is easy to notice when you 
know the expected location of coronary stenosis. The fact that CTA provided the 
exact location of stenosis is likely to contribute to the high success rate of 
measurements in Study III. However, coronary TTDE gives only limited information 
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about anatomical structures, and examination requires specific training and 
expertise on coronary anatomy. 
The study measured the ratio of maximal diastolic flow velocity to prestenotic 
flow (M/P-ratio), and the site of stenosis was located with CTA. Our findings 
confirm the prior observations that M/P-ratio is an accurate indicator of the severity 
of coronary stenosis. The study gives important additional information to previous 
studies on this subject, because our study validated the M/P-ratio for the first time 
with invasive FFR measurements. When analyzing the results, we found that the 
M/P-ratio of 2.2 was the best cut-off value to confirm the significant flow-limiting 
coronary artery stenosis. That is in line with the findings of previous studies in 
diagnosing > 50% stenosis of LAD (Hozumi et al., 2000; Caiati et al., 2009). It is 
important to measure prestenotic and maximal flow velocity close to each other to 
avoid the additive effects of consecutive lesions on the M/P-ratio. 
Numerous single- and multicenter studies have shown the strength of CTA for 
excluding significant coronary stenosis, and the NPV is high, making CTA an 
excellent tool for investigating patients with low to intermediate pretest likelihood of 
flow-limiting CAD. However, CTA has only limited capacity to diagnose the severity 
of stenosis, and the PPV is relatively low. Typically, CTA tends to overestimate the 
stenosis, especially in the presence of densely calcified coronary plaques. Our study 
provides the first demonstration that evaluation with TTDE at the site of stenosis 
located by CTA can improve the diagnostic accuracy and PPV when compared with 
CTA alone. When treating symptomatic patients in a real-life setting, it is strongly 
recommended to get an objective finding of ischemia prior to revascularization. 
TTDE is a widely available bedside technique with no radiation exposure and 
provides an excellent tool for demonstration of flow-limiting stenosis before 
deciding on the management of CAD. In this blinded study protocol, we used the 
17-segment model and predefined criteria for each coronary segment to match 
TTDE and CTA evaluation of stenosis. In real life, this could be facilitated by 
inspection of stenosis from CTA images by cardiologists, followed by 
echocardiography to further evaluate any suspected flow-limiting stenosis.     
6.2 Limitation of the studies 
The limitations of Studies I and II are that FFR could not be measured for all stenoses. 
This was due to the anatomy of some vessels and lesions as well as logistics in a busy 
invasive laboratory. The agreement between hybrid imaging and combined ICA and 
FFR was very good, but FFR also has limitations. Our goal was to evaluate all stenoses 
with borderline significance with FFR, which was possible in most patients. Another 
limitation is the relatively small patient population. Furthermore, more than half of 
the patients did not have obstructive CAD. The latter can also be regarded as 
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strength, because negative findings are important when investigating real-life patient 
populations with atypical symptoms and intermediate pretest likelihood of CAD.   
Study III was part of Study I with the same patient population. Again, all lesions 
were not evaluated with FFR. Because of that, further studies are needed in the future 
to compare the M/P-ratio with invasive hemodynamic measurements. Our study 
population included only one significant LM stenosis and six total occlusions, and 
more research is needed to clarify the results in these circumstances. Similarly, the 
number of lesions in RCA and LCX was relatively small compared with LAD, and 
segments with diameter < 1.5 mm were excluded. The value of sequential CTA and 
TTDE in these settings needs further clarification. 
6.3 Clinical implementation 
The use of coronary CTA has increased in patients with suspected CAD. Recent 
studies have provided evidence that this approach results in good clinical outcomes 
(Newby et al, 2015; Hoffmann et al, 2017). Current clinical practice guidelines 
recommend functional tests to risk stratify and identify patients with ischemia prior 
to ICA, if CTA remains inconclusive (Montalescot et al, 2013; Moss et al, 2017). Most 
of modern PET/SPECT scanners are hybrid devices, which makes anatomic and 
functional testing in the same session feasible in practice. Combination of coronary 
ultrasound and CTA remains mainly for reseach purposes due to the need for spesific 
training and skills to visualize coronary flow. In addition to other hybrid imaging 
methods, myocardial CT perfusion imaging and FFR-CT are new promising 
methods to evaluate CAD in the future (Seitun et al, 2018; Sevag Packard et al, 2017). 
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7 Conclusions 
The following conclusions may be drawn from the studies presented in this thesis. 
I  Cardiac hybrid PET/CT imaging provides accurate, noninvasive detection of 
CAD in a symptomatic population with intermediate pretest likelihood of 
CAD. 
II  Absolute quantification of MBF is an excellent diagnostic tool for evaluating 
symptomatic patients with intermediate likelihood of CAD. Absolute stress 
perfusion alone is superior to perfusion reserve when diagnosing 
hemodynamically significant coronary artery stenosis; it allows a shorter 
imaging protocol with a lower radiation dose than perfusion reserve. 
III A combination of coronary CTA and TTDE is feasible for combined anatomic 
and functional evaluation of coronary stenosis. Compared with coronary CTA 
alone, addition of TTDE improved the accuracy of diagnosing CAD. 
These results show the feasibility of hybrid imaging and demonstrate that it provides 
improved accuracy in detecting obstructive CAD as compared with stand-alone 
coronary CTA. 
  53 
Acknowledgements 
This study was carried out at the Heart Centre and the PET Centre, Turku University 
Hospital and University of Turku; Doctoral Programme in Clinical Reseach, Finland, 
during 2007-2019. 
I would like to express my sincere gratitude to the following people: 
Professor Juhani Airaksinen, MD, Director of Heart Centre Turku, and Professor 
Juhani Knuuti, MD, Director of Turku PET Centre. Your humane approach toward 
patients and colleagues, endless interest in the cardiology and clinical sciences and 
your enthusiastic spirit of living; you are both true role models to every medical 
doctor and researcher. Without your advice and support during these years this 
thesis would still be unfinished. Juhani Airaksinen has also taught me clinical 
cardiology and over the years, because of his expertise in clinical cardiology, he has 
been the person to call when important clinical decisions have to be made. I also 
want to thank him for motivating me to finish this thesis and for revising the 
manuscript. 
My supervisor, Associate Professor Antti Saraste, MD, for your never-ending 
patience during these years, for answering my questions about the data collection, 
scientific writing and practical arrangements for the study. Antti, it has been a great 
privilege for me to be your doctoral student and work with you in clinical practice. I 
appreciate your inconceivable brilliance and extraordinary expertise in cardiac 
imaging research. You kept your positive attitude and trusted me also in times when 
the project seemed very complicated to me. 
My supervisor, Docent Heikki Ukkonen, MD, for practical tutoring and 
intensive discussions from cardiology to clever humour during these years. You also 
arranged for me to have breaks from clinical work to complete this thesis. Your 
understanding way of practical management of the Heart Centre is a valuable 
humane skill and makes working easier in busy everyday life. 
All the other co-authors of the original articles: Professor Jaakko Hartiala, MD, 
Professor Juha Koskenvuo, MD, Docent Sami Kajander, MD, Docent Mikko Pietilä, 
MD, Docent Maija Mäki, MD, Docent Mika Teräs, Docent Hannu Sipilä  and 
Markku Saraste, MD for their valuable work that made clinical cardiac imaging 
possible for participants in this study.     
Esa Joutsiniemi 
 54
The reviewers of the thesis, Docent Olli Anttonen, MD, and Docent Timo 
Mäkikallio, MD, for their constructive criticism which markedly improved this 
thesis. 
Thesis follow-up committee members, Docent Risto Vesalainen, MD, and 
Docent Antti Ylitalo, MD, for supportive attitude toward my work. 
Ville Aalto for assistance with the crucial matter of statistics. 
Carolyn Abbott for revision of the English language of the thesis, and special 
thanks to Roger Duckitt, MD, for revision of the English of the acknowledgements. 
All participants in this study, without whom this work would never have been 
possible. 
All my colleagues and workmates in Turku University Hospital, Uusikaupunki 
Regional Hospital, Mehiläinen and Pihlajalinna for pleasant workdays and positive 
atmosphere. Especially, I would like to thank cardiac nurses Teija Leino, M.Sc, Taru 
Haijanen and Essi Sainio from Uusikaupunki Hospital for their unlimited patience 
in adjusting timetables in cardiac outpatient clinic. Special thanks to Riikka 
Lautamäki, Helena Tuunainen, Tuomas Paana, Ville Kytö, Samuli Jaakkola, Teemu 
Ahola and Mikko Savontaus for bringing youthful energy to the Heart Centre during 
these years.  
All my friends for kindness and support both inside and outside the academic 
world. I want use this opportunity to thank especially our golf group `Tuupparit`; 
Lassi Nelimarkka, Klaus Elenius, Mikko Pietilä, Janne Lähdesmäki, Antti 
Perheentupa, Kari Laine and Heikki Kaukavuori. During these fifteen years of golf 
every spring and autumn you have shown to me that even if you are educated, 
intelligent, scientifically appreciated, in high position, middle-aged, successful and 
talented debater you can still sometimes play lousy golf and tell terrible jokes. Thank 
you for doing that. 
My parents, Tuomo and Marja-Leena Joutsiniemi, for continuous and invaluable 
support and love that I have recived through the years. I warmly thank also my 
brothers Anssi and Hannu for giving me perspective to life outside Turku, on 
brotherhood and topics related to it. 
Finally, I devote my deepest and warmest gratitude to my dear children, Siiri and 
Alvar. Your genuine happiness brings brightness to my everyday life. You are my 
world and I love you. This work is dedicated to you.  
 
Turku, June 2019 
 
Esa Joutsiniemi 
  55 
References 
Abdulla J, Abildstrom SZ, Gotzsche O, Christensen E, Kober L, Torp-Pedersen C. 64-multislice detector 
computed tomography coronary angiography as potential alternative to conventional coronary 
angiography: a systematic review and meta-analysis.. Eur Heart J. 2007 Dec;28(24):3042-50. Epub 
2007 Nov 2. 
Anagnostopoulos C, Almonacid A, El Fakhri G, Curillova Z, Sitek A, Roughton M, Dorbala S, popma 
JJ, Di Carli MF. Quantitative relationship between coronary vasodilator reserve assessed by 82Rb 
PET imaging and coronary artery stenosis severity. Eur J Nucl Med Mol Imaging. 2008;35:1593-
601. 
Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, McGoon DC, Murphy ML, Roe 
BB. A reporting system on patients evaluated for coronary artery disease: report of the Ad Hoc 
Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, 
American Heart Association. Circulation. 1975;51:5-40. 
Bateman TM, Heller GV, McGhie AI, Friedman JD, Case JA, Bryngelson JR, Hertenstein GK, Moutray 
KL, Reid K, Cullom SJ. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion 
PET: comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol. 2006 Jan-
Feb;13(1):24-33. 
Bavry AA, Kumbhani DJ, Rassi AN, Bhatt DL, Askari AT. Benefit of early invasive therapy in acute 
coronary syndromes: a meta-analysis of contemporary randomized clinical trials. J Am Coll 
Cardiol. 2006 Oct 3;48(7):1319-25. Epub 2006 Sep 12. 
Berger A, Botman KJ, MacCarthy PA, Wijns W, Bartunek J, Heyndrickx GR, Pijls NH, De Bruyne B. 
Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary 
intervention in patients with multivessel disease. J Am Coll Cardiol. 2005;46:438-42. 
Bergmann SR, Fox KA, Rand AL, McElvany KD, Welch MJ, Markham J, Sobel BE. Quantification of 
regional myocardial blood flow in vivo with H215O. Circulation. 1984 Oct;70(4):724-33. 
Bergmann SR, Herrero P, Markham J, Weinheimer CJ, Walsh MN. Noninvasive quantitation of 
myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission 
tomography. J Am Coll Cardiol. 1989 Sep;14(3):639-52. 
Botman KJ, Pijls NH, Bech JW, Aarnoudse W, Peels K, van Straten B, Penn O, Michels HR, Bonnier H, 
Koolen JJ. Percutaneous coronary intervention or bypass surgery in multivessel disease? A tailored 
approach based on coronary pressure measuremet. Catheter Cardiovasc Interv. 2004;63:184-91. 
Budoff MJ, Dowe D, Jollis JG, Gitter M, Sutherland J, Halamert E, Scherer M, Bellinger R, Martin A, 
Benton R, Delago A, Min JK. Diagnostic performance of 64-multidetector row coronary computed 
tomographic angiography for evaluation of coronary artery stenosis in individuals without known 
coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by 
Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary 
Angiography) trial. J Am Coll Cardiol. 2008 Nov 18;52(21):1724-32. doi: 10.1016/j.jacc.2008.07.031. 
Böttcher M, Czernin J, Sun K, Phelps ME, Schelbert HR. Effect of beta 1 adrenergic receptor blockade 
on myocardial blood flow and vasodilatory capacity. J Nucl Med. 1997 Mar;38(3):442-6. 
Caiati C, Zedda N, Cadeddu M, Chen L, Montaldo C, Iliceto S, Lepera ME, Favale S. Detection, location, 
and severity assessment of left anterior descending coronary artery stenoses by means of contrast-
enhanced transthoracic harmonic echo Doppler. Eur Heart J. 2009 Jul;30(14):1797-806. doi: 
10.1093/eurheartj/ehp163. Epub 2009 May 9. 
Esa Joutsiniemi 
 56
Cerqueira MD. Advances in pharmacologic agents in imaging: new A2A receptor agonists. Curr Cardiol 
Rep. 2006 Mar;8(2):119-22. Review 
Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular 
dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med. 2003 Sep 
11;349(11):1027-35. 
Cheng VY, Berman DS, Rozanski A, Dunning AM, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri 
F, Callister TQ, Chang H-JH-JH-J, Chinnaiyan K, Chow BJW, Delago A, Gomez M, Hadamitzky 
M, Hausleiter J, Karlsberg RP, Kaufmann P, Lin FY, Maffei E, Raff GL, Villines TC, Shaw LJ, Min 
JK. Performance of the Traditional Age, Sex, and Angina Typicality-Based Approach for 
Estimating Pretest Probability of Angiographically Significant Coronary Artery Disease in Patients 
Undergoing Coronary Computed Tomographic Angiography: Results From the Mul. Circulation 
2011;124:2423–2432. 
Cremer P, Hachamovitch R, Tamarappoo B. Clinical decision making with myocardial perfusion 
imaging in patients with known or suspected coronary artery disease. Semin Nucl Med. 2014 
Jul;44(4):320-9. doi: 10.1053/j.semnuclmed.2014.04.006. 
Czernin J, Müller P, Chan S, Brunken RC, Porenta G, Krivokapich J, Chen K, Chan A, Phelps ME, 
Schelbert HR. Influence of age and hemodynamics on myocardial blood flow and flow reserve. 
Circulation. 1993 Jul;88(1):62-9. 
Danad I, Raijmakers PG, Driessen RS, Leipsic J, Raju R, Naoum C, Knuuti J, Mäki M, Underwood RS, 
Min JK, Elmore K, Stuijfzand WJ, van Royen N, Tulevski II, Somsen AG, Huisman MC, van Lingen 
AA, Heymans MW, van de Ven PM, van Kuijk C, Lammertsma AA, van Rossum AC, Knaapen P. 
Comparison of Coronary CT Angiography, SPECT, PET, and Hybrid Imaging for Diagnosis of 
Ischemic Heart Disease Determined by Fractional Flow Reserve. JAMA Cardiol. 2017 Oct 
1;2(10):1100-7. doi: 10.1001/jamacardio.2017.2471 
Danad I, Uusitalo V, Kero T, Saraste A, Raijmakers PG, Lammertsma AA, Heymans MW, Kajander SA, 
Pietilä M, James S, Sörensen J, Knaapen P, Knuuti J. Quantitative assessment of myocardial 
perfusion in the detection of significant coronary artery disease: cutoff values and diagnostic 
accuracy of quantitative [(15)O]H2O PET imaging. J Am Coll Cardiol. 2014 Oct 7;64(14):1464-75. 
doi: 10.1016/j.jacc.2014.05.069. 
Dehmer GJ, Weaver D, Roe MT, Milford-Beland S, Fitzgerald S, Hermann A, Messenger J, Moussa I, 
Garratt K, Rumsfeld J, Brindis RG. A contemporary view of diagnostic cardiac catheterization and 
percutaneous coronary intervention in the United States: a report from the CathPCI Registry of 
the National Cardiovascular Data Registry, 2010 through June 2011. J Am Coll Cardiol. 2012 Nov 
13;60(20):2017-31. doi: 10.1016/j.jacc.2012.08.966. Epub 2012 Oct 17. 
Diamond GA. A clinically relevant classification of chest discomfort. J Am Coll Cardiol. 1983 Feb;1(2 
Pt 1):574-5.  
Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery 
disease. N Engl J Med. 1979 Jun 14;300(24):1350-8. 
Diamond GA, Staniloff HM, Forrester JS, Pollock BH, Swan HJC. Computer-assisted diagnosis in the 
non-invasive evaluation of patients with suspected coronary-artery disease. J Am Coll Cardiol. 
1983;1:444-5. 
Di Carli M, Czernin J, Hoh CK, Gerbaudo VH, Brunken RC, Huang SC, Phelps ME, Schelbert HR. 
Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with 
coronary artery disease. Circulation. 1995 Apr 1;91(7):1944-51. 
Di Carli MF, Dorbala S. Cardiac PET-CT. J Thorac Imaging. 2007;22:101-6. 
Di Carli MF, Dorbala S, Meserve J, El Fakhri G, Sitek A, Moore SC. Clinical myocardial perfusion 
PET/CT. J Nucl Med. 2007;48:783-93.  
Di Carli MF, Hachamovitch R. New technology for noninvasive evaluation of coronary artery disease. 
Circulation. 2007;115:1464-80. 
Di Mario C, Meneveau N, Gil R, de Jaegere P, de Feyter PJ, Slager CJ, Roelandt JR, Serruys PW. Maximal 
blood flow velocity in severe coronary stenoses measured with a Doppler guidewire. Limitations 
for the application of the continuity equation in the assessment of stenosis severity. Am J Cardiol. 
1993 May 20;71(14):54D-61D. 
References 
 57 
Di Tanna GL, Berti E, Stivanello E, Cademartiri F, Achenbach S, Camerlingo MD, Grilli R. Informative 
value of clinical research on multislice computed tomography in the diagnosis of coronary artery 
disease: A systematic review. Int J Cardiol. 2008 Nov 28;130(3):386-404. doi: 
10.1016/j.ijcard.2008.06.032. Epub 2008 Aug 30. 
Dorbala S, Di Carli MF. Cardiac PET perfusion: prognosis, risk stratification, and clinical management. 
Semin Nucl Med. 2014 Sep;44(5):344-57. doi:10.1053/j.semnuclmed.2014.05.003. 
Dorbala S, Di Carli MF, Beanlands RS, Merhige ME, Williams BA, Veledar E, Chow BJW, Min JK, 
Pencina MJ, Berman DS, Shaw LJ. Prognostic Value of Stress Myocardial Perfusion Positron 
Emission Tomography: Results From a Multicenter Observational Registry. Journal of the 
American College of Cardiology, Volume 61, Issue 2, 15 January 2013, Pages 176–84.  
El Fakhri G, Kardan A, Sitek A, Dorbala S, Abi-Hatem N, Lahoud Y, Fischman A, Coughlan M, Yasuda 
T, Di Carli MF. Reproducibility and accuracy of quantitative myocardial blood flow assessment 
with (82)Rb PET: comparison with (13)N-ammonia PET. J Nucl Med. 2009;50:1062-71. 
Elgendy IY, Kumbhani DJ, Mahmoud AN, Wen X, Bhatt DL, Bavry AA. Routine invasive versus 
selective invasive strategies for Non-ST-elevation acute coronary syndromes: An Updated meta-
analysis of randomized trials. Catheter Cardiovasc Interv. 2016 Nov;88(5):765-74. doi: 
10.1002/ccd.26679. Epub 2016 Aug 12. Review.  
Fiechter M, Ghadri JR, Gebhard C, Fuchs TA, Pazhenkottil AP, Nkoulou RN, Herzog BA, Wyss CA, 
Gaemperli O, Kaufmann PA. Diagnostic value of 13N-ammonia myocardial perfusion PET: added 
value of myocardial flow reserve. J Nucl Med. 2012 Aug;53(8):1230-4. doi: 
10.2967/jnumed.111.101840. Epub 2012 Jun 29. 
Fordyce CB, Newby DE, Douglas PS. Diagnostic Strategies for the Evaluation of Chest Pain: Clinical 
Implications From SCOT-HEART and PROMISE. J Am Coll Cardiol. 2016 Feb 23;67(7):843-52. 
doi: 10.1016/j.jacc.2015.11.055. Review. 
Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, De Backer G, Hjemdahl P, 
Lopez-Sendon J, Marco J, Morais J, Pepper J, Sechtem U, Simoons M, Thygesen K, Priori SG, Blanc 
JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, 
Osterspey A, Tamargo J, Zamorano JL. Guidelines on the management of stable angina pectoris: 
executive summary: The Task Force on the Management of Stable Angina Pectoris of the European 
Society of Cardiology. Task Force on the Management of Stable Angina Pectoris of the European 
Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Eur Heart J. 2006 
Jun;27(11):1341-81. Epub 2006 May 30. 
Froelicher VF, Lehmann KG, Thomas R, Goldman S, Morrison D, Edson R, Lavori P, Myers J, Dennis 
C, Shabetai R, Do D, Froning J. The electrocardiographic exercise test in a population with reduced 
workup bias: diagnostic performance, computerized interpretation, and multivariable prediction. 
Veterans Affairs Cooperative Study in Health Services #016 (QUEXTA) Study Group. Quantitative 
Exercise Testing and Angiography. Ann Intern Med. 1998 Jun 15;128(12 Pt 1):965-74. 
Gaemperli O, Saraste A, Knuuti J. Cardiac hybrid imaging. Eur Heart J Cardiovasc Imaging. 2012 
Jan;13(1):51-60. doi: 10.1093/ejechocard/jer240. Epub 2011 Nov 17. Review 
Gaemperli O, Schepis T, Koepfli P, Valenta I, Soyka J, Leschka S, Desbiolles L, Husmann L, Alkadhi H, 
Kaufmann PA. Accuracy of 64-slice CT angiography for the detection of functionally relevant 
coronary stenoses as assessed with myocardial perfusion SPECT. Eur J Nucl Med Mol Imaging. 
2007 Aug;34(8):1162-71. Epub 2007 Jan 12 
GBD 2016 Causes of Death Collaborators.Global, regional, and national age-sex specific mortality for 
264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. 
Lancet. 2017Sep 16;390(10100):1151-210. doi:10.1016/S0140-6736(17)32152-9. 
Genders TSS, Steyerberg EW, Alkadhi H, Leschka S, Desbiolles L, Nieman K, Galema TW, Meijboom 
WB, Mollet NR, Feyter PJ de, Cademartiri F, Maffei E, Dewey M, Zimmermann E, Laule M, 
Pugliese F, Barbagallo R, Sinitsyn V, Bogaert J, Goetschalckx K, Schoepf UJ, Rowe GW, Schuijf JD, 
Bax JJ, Graaf FR de, Knuuti J, Kajander S, Mieghem CAG van, Meijs MFL, Cramer MJ, Gopalan 
D, Feuchtner G, Friedrich G, Krestin GP, Hunink MG; CAD Consortium. A clinical prediction 
rule for the diagnosis of coronary artery disease: validation, updating, and extension. Eur Heart J 
2011;32:1316–1330. 
Esa Joutsiniemi 
 58
Genders TSS, Steyerberg EW, Hunink MGM, Nieman K, Galema TW, Mollet NR, Feyter PJ d., Krestin 
GP, Alkadhi H, Leschka S, Desbiolles L, Meijs MFL, Cramer MJ, Knuuti J, Kajander S, Bogaert J, 
Goetschalckx K, Cademartiri F, Maffei E, Martini C, Seitun S, Aldrovandi A, Wildermuth S, Stinn 
B, Fornaro J, Feuchtner G, Zordo T De, Auer T, Plank F, Friedrich G, Pugliese F, Petersen SE, 
Davies LC, Schoepf UJ, Rowe GW, van Mieghem CA, van Driessche L, Sinitsyn V, Gopalan D, 
Nikolaou K, Bamberg F, Cury RC, Battle J, Maurovich-Horvat P, Bartykowszki A, Merkely B, 
Becker D, Hadamitzky M, Hausleiter J, Dewey M, Zimmermann E, Laule M. Prediction model to 
estimate presence of coronary artery disease: retrospective pooled analysis of existing cohorts. BMJ 
2012;344:e3485–e3485. 
Gibbons RJ. Noninvasive diagnosis and prognosis assessment in chronic coronary artery disease: stress 
testing with and without imaging perspective. Circ Cardiovasc Imaging. 2008 Nov;1(3):257-69; 
discussion 269. doi: 10.1161/CIRCIMAGING.108.823286. 
Gibbons RJ, Balady GJ, Beasley JW, Bricker JT, Duvernoy WF, Froelicher VF, Mark DB, Marwick TH, 
McCallister BD, Thompson PD, Winters WL Jr, Yanowitz FG, Ritchie JL, Cheitlin MD, Eagle KA, 
Gardner TJ, Garson A Jr, Lewis RP, O'Rourke RA, Ryan TJ. ACC/AHA guidelines for exercise 
testing: executive summary. A report of the American College of Cardiology/American Heart 
Association Task Force on Practice Guidelines (Committee on Exercise Testing). Circulation. 1997 
Jul 1;96(1):345-54. 
Goetz RH, Rohman M, Haller JD, Dee R, Rosenak SS. Internal mammary-coronary artery anastomosis. 
A nonsuture method employing tantalum rings. J Thorac Cardiovasc Surg. 1961 Mar;41:378-86. 
Gould KL. Assessment of coronary stenoses with myocardial perfusion imaging during pharmacologic 
coronary vasodilatation. IV. Limits of detection of stenosis with idealized experimental cross-
sectional myocardial imaging. Am J Cardiol. 1978 Nov;42(5):761-8. 
Groves AM, Speechly-Dick ME, Kayani I, Pugliese F, Endozo R, McEwan J, Menezes LJ, Habib SB, 
Prvulovich E, Ell PJ. First experience of combined cardiac PET/64-detector CT angiography with 
invasive angiographic validation. Eur J Nucl Med Mol Imaging. 2009 Dec;36(12):2027-33. doi: 
10.1007/s00259-009-1213-y. 
Gruntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet. 1978, vol.1(8058):263 
Gruentzig AR, King III SB, Schlumpf M, Siegenthaler W. Long-term follow-up after percutaneous 
transluminal coronary angioplasty. The early Zurich experience. N Engl J Med, 316 (1987), pp. 
1127-32 
Gueret P, Deux J-F, Bonello L, Sarran A, Tron C, Christiaens L, Dacher J-N, Bertrand D, Leborgne L, 
Renard C, Caussin C, Cluzel P, Helft G, Crochet D, Vernhet-Kovacsik H, Chabbert V, Ferrari E, 
Gilard M, Willoteaux S, Furber A, Barone-Rochette G, Jankowski A, Douek P, Mousseaux E, Sirol 
M, Niarra R, Chatellier G, Laissy J-P. Diagnostic Performance of Computed Tomography 
Coronary Angiography (from the Prospective National Multicenter Multivendor EVASCAN 
Study). Am J Cardiol 2013;111:471–478. 
Guthaner DF, Wexler L, Harell G. CT demonstration of cardiac structures. AJR Am J Roentgenol. 1979 
Jul;133(1):75-81. 
Hack SN, Eichling JO, Bergmann SR, Welch MJ, Sobel BE. External quantification of myocardial 
perfusion by exponential infusion of positron-emitting radionuclides. J Clin Invest. 1980 
Nov;66(5):918-27. 
Hajjiri MM, Leavitt MB, Zheng H, Spooner AE, Fischman AJ, Gewirtz H. Comparison of positron 
emission tomography measurement of adenosine-stimulated absolute myocardial blood flow 
versus relative myocardial tracer content for physiological assessment of coronary artery stenosis 
severity and location. JACC Cardiovasc Imaging. 2009 Jun;2(6):751-8. doi: 
10.1016/j.jcmg.2009.04.004. 
Heller GV, Calnon D, Dorbala S. Recent advances in cardiac PET and PET/CT myocardial perfusion 
imaging. J Nucl Cardiol. 2009 Nov-Dec;16(6):962-9. doi: 10.1007/s12350-009-9142-5 
Herzog BA, Husmann L, Valenta I, Gaemperli O, Siegrist PT, Tay FM, Burkhard N, Wyss CA, 
Kaufmann PA. Long-term prognostic value of 13N-ammonia myocardial perfusion positron 
emission tomography added value of coronary flow reserve. J Am Coll Cardiol. 2009 Jul 
7;54(2):150-6. doi: 10.1016/j.jacc.2009.02.069. 
References 
 59 
Higashiue S, Watanabe H, Yokoi Y, Takeuchi K, Yoshikawa J. Simple detection of severe coronary 
stenosis using transthoracic Doppler echocardiography at rest. Am J Cardiol. 2001 May 
1;87(9):1064-8. 
Holte E, Vegsundvåg J, Hegbom K, Hole T, Wiseth R. Transthoracic Doppler for detection of stenoses 
in the three main coronary arteries by use of stenotic to prestenotic velocity ratio and aliased 
coronary flow. Eur Heart J Cardiovasc Imaging. 2015 Dec;16(12):1323-30. doi: 10.1093/ehjci/jev158. 
Epub 2015 Jun 25. 
Hoffmann U, Ferencik M, Udelson JE, Picard MH, Truong QA, Patel MR, Huang M, Pencina M, Mark 
DB, Heitner JF, Fordyce CB, Pellikka PA, Tardif JC, Budoff M, Nahhas G, Chow B, Kosinski AS, 
Lee KL, Douglas PS; PROMISE Investigators. Prognostic Value of Noninvasive Cardiovascular 
Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective 
Multicenter Imaging Study for Evaluation of Chest Pain). Circulation. 2017 Jun 13;135(24):2320-
32. doi: 10.1161/CIRCULATIONAHA.116.024360. Epub 2017 Apr 7. 
Hozumi T, Yoshida K, Akasaka T, Asami Y, Kanzaki Y, Ueda Y, Yamamuro A, Takagi T, Yoshikawa J. 
Value of acceleration flow and the prestenotic to stenotic coronary flow velocity ratio by 
transthoracic color Doppler echocardiography in noninvasive diagnosis of restenosis after 
percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 2000 Jan;35(1):164-8. 
Hozumi T, Yoshida K, Akasaka T, Asami Y, Ogata Y, Takagi T, Kaji S, Kawamoto T, Ueda Y, Morioka 
S. Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left 
anterior descending coronary artery by Doppler echocardiography: comparison with invasive 
technique. J Am Coll Cardiol, 32 (1998), pp. 1251-9 
Hozumi T, Yoshida K, Ogata Y, Akasaka T, Asami Y, Takagi T, Morioka S. Noninvasive assessment of 
significant left anterior descending coronary artery stenosis by coronary flow velocity reserve with 
transthoracic color Doppler echocardiography. Circulation. 1998 Apr 28;97(16):1557-62. 
Hurlock GS, Higashino H, Mochizuki T. History of cardiac computed tomography: single to 320-
detector row multislice computed tomography. Int J Cardiovasc Imaging. 2009 Apr;25 Suppl 1:31-
42. doi: 10.1007/s10554-008-9408-z. Epub 2009 Jan 15. Review. 
Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE. Noninvasive 
quantification of regional blood flow in the human heart using N-13 ammonia and dynamic 
positron emission tomographic imaging. J Am Coll Cardiol. 1990;15:1032-42 
Hutton BF. The origins of SPECT and SPECT/CT. Eur J Nucl Med Mol Imaging. 2014 May;41 Suppl 
1:S3-16. doi: 10.1007/s00259-013-2606-5. Epub 2013 Nov 12. Review 
Jaarsma C, Leiner T, Bekkers SC, Crijns HJ, Wildberger JE, Nagel E, Nelemans PJ, Schalla S. Diagnostic 
performance of noninvasive myocardial perfusion imaging using single-photon emission 
computed tomography, cardiac magnetic resonance, and positron emission tomography imaging 
for the detection of obstructive coronary artery disease: a meta-analysis. J Am Coll Cardiol. 2012 
May 8;59(19):1719-28. doi: 10.1016/j.jacc.2011.12.040. 
Javadi M, Mahesh M, McBride G, Voicu C, Epley W, Merrill J, Bengel FM. Lowering radiation dose for 
integrated assessment of coronary morphology and physiology: first experience with step-and-
shoot CT angiography in a rubidium 82 PET-CT protocol. J Nucl Cardiol. 2008;15:783-90. 
Johnson NP, Gould KL. Integrating noninvasive absolute flow, coronary flow reserve, and ischemic 
thresholds into a comprehensive map of physiological severity. JACC Cardiovasc Imaging. 2012 
Apr;5(4):430-40. doi: 10.1016/j.jcmg.2011.12.014. 
Kajander SA, Joutsiniemi E, Saraste M, Pietilä M, Ukkonen H, Saraste A, Sipilä HT, Teräs M, Mäki M, 
Airaksinen J, Hartiala J, Knuuti J. Clinical value of absolute quantification of myocardial perfusion 
with (15)O-water in coronary artery disease. Circ Cardiovasc Imaging. 2011 Nov;4(6):678-84. doi: 
10.1161/CIRCIMAGING.110.960732. Epub 2011 Sep 16. 
Kajander S, Ukkonen H, Sipila H, Teras M, Knuuti J. Low radiation dose imaging of myocardial 
perfusion and coronary angiography with a hybrid PET/CT scanner. Clin Physiol Funct Imaging. 
2009;29:81-8. 
Kenny A, Shapiro LM. Transthoracic high-frequency two-dimensional echocardiography, Doppler and 
color flow mapping to determine anatomy and blood flow patterns in the distal left anterior 
descending coronary artery. Am J Cardiol. 1992 May 15;69(16):1265-8. 
Esa Joutsiniemi 
 60
Kern MJ, Lerman A, Bech JW, de Bruyne B, Eeckhout E, Fearon WF, Higano ST, Lim MJ, Meuwissen 
M, Piek JJ, Pijls NH, Siebes M, Spaan JA ; American Heart Association Committee on Diagnostic 
and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Physiological 
assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific 
statement from the American Heart Association Committee on Diagnostic and Interventional 
Cardiac Catheterization, Council on Clinical Cardiology. Circulation, 114 (2006), pp. 1321-41 
King SB 3rd, Schlumpf M. "Ten-year completed follow-up of percutaneous transluminal coronary 
angioplasty: the early Zurich experience". J Am Coll Cardiol. 22(2):353–60.(1993) doi:10.1016/0735-
1097(93)90037-2. PMID 8335804. 
Knuuti J, Ballo H, Juarez-Orozco LE, Saraste A, Kolh P, Rutjes AWS, Jüni P, Windecker S, Bax JJ, Wijns 
W. The performance of non-invasive tests to rule-in and rule-out significant coronary artery 
stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability. Eur 
Heart J. 2018 Sep 14;39(35):3322-30. doi: 10.1093/eurheartj/ehy267 
Knuuti J, Kajander S, Mäki M, Ukkonen H. Quantification of myocardial blood flow will reform the 
detection of CAD. J Nucl Cardiol. 2009 Jul-Aug; 16(4):497-506. doi: 10.1007/s12350-009-9101-1. 
Epub 2009 Jun 3. 
Knuuti J, Saraste A. Advances in clinical application of quantitative myocardial perfusion imaging. J 
Nucl Cardiol. 2012 Aug;19(4):643-6. doi: 10.1007/s12350-012-9530-0. 
Koepfli P, Hany TF, Wyss CA, Namdar M, Burger C, Konstantinidis AV, Berthold T, Von Schulthess 
GK, Kaufmann PA. CT attenuation correction for myocardial perfusion quantification using a 
PET/CT hybrid scanner. J Nucl Med. 2004 Apr;45(4):537-42. 
Kovanen PT, Kardiologia, 3. painos, 2016 
Krzanowski M, Bodzoń W, Brzostek T, Nizankowski R, Szczeklik A. Value of transthoracic 
echocardiography for the detection of high-grade coronary artery stenosis: prospective evaluation 
in 50 consecutive patients scheduled for coronary angiography. J Am Soc Echocardiogr. 2000 
Dec;13(12):1091-9. 
Krzanowski M, Bodzoń W, Dimitrow PP. Imaging of all three coronary arteries by transthoracic 
echocardiography. An illustrated guide. Cardiovasc Ultrasound. 2003 Nov 17;1:16. 
Lautamaki R, George RT, Kitagawa K, Higuchi T, Merrill J, Voicu C, Di Paula A, Nekolla SG, Lima JA, 
Lardo AC, Bengel FM. Rubidium-82 PET-CT for quantitative assessment of myocardial blood 
flow: validation in a canine model of coronary artery stenosis. Eur J Nucl Med Mol Imaging. 
2009;36:576-86. 
Lortie M, Beanlands RS, Yoshinaga K, Klein R, Dasilva JN, DeKemp RA. Quantification of myocardial 
blood flow with 82-Rb dynamic PET imaging. Eur J Nucl Med Mol Imaging. 2007;34:1765-74. 
Maaniitty T, Stenström I, Bax JJ, Uusitalo V, Ukkonen H, Kajander S, Mäki M, Saraste A, Knuuti J. 
Prognostic Value of Coronary CT Angiography With Selective PET Perfusion Imaging in 
Coronary Artery Disease. JACC: Cardiovascular Imaging, Volume 10, Issue 11, 2017, pp. 1361-70 
Maddahi J, Packard RRS. Cardiac PET Perfusion Tracers: Current Status and Future Directions. 
Seminars in Nuclear Medicine, Volume 44, Issue 5, 2014, pp. 333-43 
Mancini GBJ, Hartigan PM, Shaw LJ, Berman DS, Hayes SW, Bates ER, Maron DJ, Teo K, Sedlis SP, 
Chaitman BR, Weintraub WS, Spertus JA, Kostuk WJ, Dada M, Booth DC, Boden WE. Predicting 
outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive 
Drug Evaluation): coronary anatomy versus ischemia. JACC Cardiovasc Interv. 2014 Feb;7(2):195-
201. doi: 10.1016/j.jcin.2013.10.017. Epub 2014 Jan 15 
Mark DB, Shaw L, Harrell FE, Hlatky MA, Lee KL, Bengtson JR, McCants CB, Califf RM, Pryor DB. 
Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. 
N Engl J Med 1991;325:849–853. 
Matsumura Y, Hozumi T, Watanabe H, Fujimoto K, Sugioka K, Takemoto Y, Shimada K, Muro T, 
Yoshiyama M, Takeuchi K, Yoshikawa J. Cut-off value of coronary flow velocity reserve by 
transthoracic Doppler echocardiography for diagnosis of significant left anterior descending artery 
stenosis in patients with coronary risk factors. Am J Cardiol. 2003 Dec 15;92(12):1389-93. 
McGinn AL, White CW, Wilson RF. Interstudy variability of coronary flow reserve. Influence of heart 
rate, arterial pressure, and ventricular preload. Circulation. 1990 Apr;81(4):1319-30. 
References 
 61 
Meijboom WB, Meijs MF, Schuijf JD, Cramer MJ, Mollet NR, van Mieghem CA, Nieman K, van 
Werkhoven JM, Pundziute G, Weustink AC, de Vos AM, Pugliese F, Rensing B, Jukema JW, Bax 
JJ, Prokop M, Doevendans PA, Hunink MG, Krestin GP, de Feyter PJ. Diagnostic accuracy of 64-
slice computed tomography coronary angiography: a prospective, multicenter, multivendor study. 
J Am Coll Cardiol. 2008 Dec 16;52(25):2135-44. doi: 10.1016/j.jacc.2008.08.058. 
Meijboom WB, Van Mieghem CAG, van Pelt N, Weustink A, Pugliese F, Mollet NR, Boersma E, Regar 
E, van Geuns RJ, de Jaegere PJ, Serruys PW, Krestin GP, de Feyter PJ. Comprehensive assessment 
of coronary artery stenosis: computed tomography coronary angiography versus conventional 
coronary angiography and correlation with fractional flow reserve in patients with stable angina. J 
Am Coll Cardiol. 2008;52:636-43. 
Melikian N, De Bondt P, Tonino P, De Winter O, Wyffels E, Bartunek J, Heyndrickx GR, Fearon WF, 
Pijls NH, Wijns W, De Bruyne B. Fractional flow reserve and myocardial perfusion imaging in 
patients with angiographic multivessel coronary artery disease. JACC Cardiovasc Interv. 2010 
Mar;3(3):307-14. doi: 10.1016/j.jcin.2009.12.010. 
Mieres JH, Shaw LJ, Arai A, Budoff MJ, Flamm SD, Hundley WG, Marwick TH, Mosca L, Patel AR, 
Quinones MA, Redberg RF, Taubert KA, Taylor AJ, Thomas GS, Wenger NK; Cardiac Imaging 
Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention 
Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. 
Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery 
disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical 
Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on 
Cardiovascular Radiology and Intervention, American Heart Association. Circulation. 2005 Feb 
8;111(5):682-96. Epub 2005 Feb 1 
Miller JM, Rochitte CE, Dewey M, Arbab-Zadeh A, Niinuma H, Gottlieb I, Paul N, Clouse ME, Shapiro 
EP, Hoe J, Lardo AC, Bush DE, de Roos A, Cox C, Brinker J, Lima JA. Diagnostic performance of 
coronary angiography by 64-row CT. N Engl J Med. 2008;359:2324-36. 
Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset 
T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, 
Ruschitzka F, Sabaté M, Senior R, Taggart DP, van der Wall EE, Vrints CJ; ESC Committee for 
Practice Guidelines, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton 
C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, 
Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, 
Torbicki A, Wijns W, Windecker S; Document Reviewers, Knuuti J, Valgimigli M, Bueno H, Claeys 
MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey 
JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, 
Maggioni AP, Piepoli MF, Pries AR, Romeo F, Rydén L, Simoons ML, Sirnes PA, Steg PG, Timmis 
A, Wijns W, Windecker S, Yildirir A, Zamorano JL. ESC guidelines on the management of stable 
coronary artery disease: the Task Force on the management of stable coronary artery disease of the 
European Society of Cardiology. Eur Heart J. 2013 Oct;34(38):2949-3003. doi: 
10.1093/eurheartj/eht296. Epub 2013 Aug 30.2013 ESC 
Morise AP, Diamond GA. Comparison of the sensitivity and specificity of exercise electrocardiography 
in biased and unbiased populations of men and women. Am Heart J. 1995 Oct;130(4):741-7. 
Morita K, Inoue T, Okamoto S, Hirata K, Tamaki N. Clinical value of 13N-ammonia PET in assessment 
of cardiac disease: a meta-analyses [in Japanese]. Kaku Igaku. 2007;44:365-372. 
Moss AJ, Williams MC, Newby DE, Nicol ED. The Updated NICE Guidelines: Cardiac CT as the First-
Line Test for Coronary Artery Disease. Curr Cardiovasc Imaging Rep. 2017;10(5):15. doi: 
10.1007/s12410-017-9412-6. Epub 2017 Mar 27. Review 
Mowatt G, Cook JA, Hillis GS, Walker S, Fraser C, Jia X, Waugh N. 64-Slice computed tomography 
angiography in the diagnosis and assessment of coronary artery disease: systematic review and 
meta-analysis. Heart. 2008 Nov;94(11):1386-93. doi: 10.1136/hrt.2008.145292. Epub 2008 Jul 31.  
Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Di Carli G, Blankstein R, Dorbala S, Sitek A, 
Pencina MJ, Di Carli MF. Improved cardiac risk assessment with noninvasive measures of 
Esa Joutsiniemi 
 62
coronary flow reserve. Circulation. 2011 Nov 15;124(20):2215-24. doi: 
10.1161/CIRCULATIONAHA.111.050427. Epub 2011 Oct 17. 
Muzik O, Duvernoy C, Beanlands RS, Sawada S, Dayanikli F, Wolfe ER Jr, Schwaiger M. Assessment of 
diagnostic performance of quantitative flow measurements in normal subjects and patients with 
angiographically documented coronary artery disease by means of nitrogen-13 ammonia and 
positron emission tomography. J Am Coll Cardiol. 1998 Mar 1;31(3):534-40. 
Namdar M, Hany TF, Koepfli P, Siegrist PT, Burger C, Wyss CA, Luscher TF, von Schulthess GK, 
Kaufmann PA. Integrated PET/CT for the assessment of coronary artery disease: a feasibility study. 
J Nucl Med. 2005 Jun;46(6):930-5. 
Nandalur KR, Dwamena BA, Choudhri AF, Nandalur SR, Reddy P, Carlos RC. Diagnostic performance 
of positron emission tomography in the detection of coronary artery disease: a meta-analysis. Acad 
Radiol. 2008 Apr;15(4):444-51. doi: 10.1016/j.acra.2007.08.012 
Naya M, Murthy VL, Taqueti VR, Foster CR, Klein J, Garber M, et al. Preserved coronary flow reserve 
effectively excludes high-risk coronary artery disease on angiography. J Nucl Med 2014;55:248-55. 
Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A, Pratali L, Gallopin M, Salvadori P, 
Sorace O, Carpeggiani C, Poddighe R, L'Abbate A, Parodi O. Prognostic role of myocardial blood 
flow impairment in idiopathic left ventricular dysfunction. Circulation. 2002 Jan 15;105(2):186-93. 
Nekolla SG, Reder S, Saraste A, Higuchi T, Dzewas G, Preissel A, Huisman M, Poethko T, Schuster T, 
Yu M, Robinson S, Casebier D, Henke J, Wester HJ, Schwaiger M. Evaluation of the novel 
myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 
13N-ammonia and validation with microspheres in a pig model. Circulation. 2009 May 
5;119(17):2333-42. doi: 10.1161/CIRCULATIONAHA.108.797761. Epub 2009 Apr 20. 
Nesterov SV, Han C, Mäki M, Kajander S, Naum AG, Helenius H, Lisinen I, Ukkonen H, Pietilä M, 
Joutsiniemi E, Knuuti J. Myocardial perfusion quantitation with 15O-labelled water PET: high 
reproducibility of the new cardiac analysis software (Carimas). Eur J Nucl Med Mol Imaging. 2009 
Oct;36(10):1594-602. doi: 10.1007/s00259-009-1143-8. Epub 2009 Apr 30. Erratum in: Eur J Nucl 
Med Mol Imaging. 2010 Apr;37(4):832. 
Newby D, Williams M, Hunter A, Pawade T, Shah A, Newby D, Flapan A, Forbes J, Hargreaves A, Leslie 
S, Lewis S, McKillop G, McLean S, Reid J, Spratt J, Uren N, Timmis A, Berry C, Boon N, Clark L, 
Craig P, Barlow T, Flather M, Forbes J, Lewis S, McCormack C, McLean S, Newby D, Roditi G, van 
Beek E, Williams M, Hunter A, Shepherd S, Bucukoglu M, Lewis S, Assi V, Parker R, Krishan A, 
McCormack C, Wee F, Wackett A, Walker A, Milne L, Oatey K, Neary P, Donaldson G, Fairbairn 
T, Fotheringham M, Hall F, Hargreaves A, Spratt J, Glen S, Perkins S, Taylor F, Cram L, Beveridge 
C, Cairns A, Dougherty F, Eteiba H, Rae A, Robb K, Crawford W, Clarkin P, Lennon E, Houston 
G, Pringle S, Ramkumar PG, Sudarshan T, Fogarty Y, Barrie D, Bissett K, Dawson A, Dundas S, 
Letham D, O'Neill L, Ritchie V, Weir-McCall J, Dougall H, Ahmed F, Cormack A, Findlay I, Hood 
S, Murphy C, Peat E, McCabe L, McCubbin M, Allen B, van Beek E, Behan M, Bertram D, Brian 
D, Cowan A, Cruden N, Denvir M, Dweck M, Flint L, Flapan A, Fyfe S, Grubb N, Keanie C, Lang 
C, MacGillivray T, MacLachlan D, MacLeod M, Mirsadraee S, Morrison A, Mills N, Northridge D, 
Phillips A, Queripel L, Reid J, Uren N, Weir N, Jacob A, Bett F, Divers F, Fairley K, Keegan E, 
White T, Fowler J, Gemmill J, McGowan J, Henry M, Francis M, Sandeman D, Dinnel L, Newby 
D, Bloomfield P, Denvir M, Henriksen P, MacLeod D, Morrison A, Berry C, Mangion K, Mordi I, 
Roditi G, Tzemos N, Connolly E, Boylan H, Brown A, Farrell L, Frood A, Glover C, Johnstone J, 
Lanaghan K, McGlynn D, McGregor L, McLennan E, Murdoch L, Paterson V, Teyhan F, Teenan 
M, Woodward R, Steedman T. SCOT-HEART investigators. CT coronary angiography in patients 
with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-
group, multicentre trial. Lancet. 2015 Jun 13;385(9985):2383-91. doi: 10.1016/S0140-
6736(15)60291-4. Epub 2015 Mar 15. 
Newby DE, Adamson PD, Berry C, Boon NA, Dweck MR, Flather M, Forbes J, Hunter A, Lewis S, 
MacLean S, Mills NL, Norrie J, Roditi G, Shah AS V, Timmis AD, Beek EJR van, Williams MC, 
SCOT-HEART Investigators. Coronary CT Angiography and 5-Year Risk of Myocardial 
Infarction. N Engl J Med 2018;379:924–933. 
References 
 63 
Nieman K, Cademartiri F, Lemos PA, Raaijmakers R, Pattynama PM, de Feyter PJ. Reliable noninvasive 
coronary angiography with fast submillimeter multislice spiral computed tomography. Circulation 
2002 Oct 15;106(16):2051-4. 
van Nunen LX, Zimmermann FM, Tonino PA, Barbato E, Baumbach A, Engstrøm T, Klauss V, 
MacCarthy PA, Manoharan G, Oldroyd KG, Ver Lee PN, Van't Veer M, Fearon WF, De Bruyne B, 
Pijls NH; FAME Study Investigators. Fractional flow reserve versus angiography for guidance of 
PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised 
controlled trial. Lancet. 2015 Nov 7;386(10006):1853-60. doi: 10.1016/S0140-6736(15)00057-4. 
Epub 2015 Aug 30. 
Okin PM, Kligfield P. Gender-specific criteria and performance of the exercise electrocardiogram. 
Circulation. 1995 Sep 1;92(5):1209-16. 
Otsuka R, Watanabe H, Hirata K, Tokai K, Muro T, Hozumi T, Yoshiyama M, Yoshikawa J. A novel 
technique to detect total occlusion in the right coronary artery using retrograde flow by 
transthoracic Doppler echocardiography. J Am Soc Echocardiogr. 2005 Jul;18(7):704-9. 
Ozdemir M, Yazici GE, Turkoglu S, Timurkaynak T, Cengel A. Metoprolol does not effect myocardial 
fractional flow reserve in patients with intermediate coronary stenoses. Int Heart J. 2007 
Jul;48(4):477-83. 
Parkash R, deKemp RA, Ruddy TD, Kitsikis A, Hart R, Beauchesne L, Williams K, Davies RA, Labinaz 
M, Beanlands RS. Potential utility of rubidium 82 PET quantification in patients with 3-vessel 
coronary artery disease. J Nucl Cardiol. 2004 Jul-Aug;11(4):440-9. 
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, 
Deaton C, Graham I, Hall MS, Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, 
Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, 
Verschuren WM; Additional Contributor: Simone Binno (Italy); Document Reviewers:, De Backer 
G, Roffi M, Aboyans V, Bachl N, Bueno H, Carerj S, Cho L, Cox J, De Sutter J, Egidi G, Fisher M, 
Fitzsimons D, Franco OH, Guenoun M, Jennings C, Jug B, Kirchhof P, Kotseva K, Lip GY, Mach 
F, Mancia G, Bermudo FM, Mezzani A, Niessner A, Ponikowski P, Rauch B, Rydén L, Stauder A, 
Turc G, Wiklund O, Windecker S, Zamorano JL. 2016 European Guidelines on cardiovascular 
disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of 
Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice 
(constituted by representatives of 10 societies and by invited experts): Developed with the special 
contribution of the European Association for Cardiovascular Prevention & Rehabilitation 
(EACPR). Eur J Prev Cardiol. 2016 Jul;23(11):NP1-NP96. doi: 10.1177/2047487316653709. Epub 
2016 Jun 27. 
Pijls NH. Optimum guidance of complex PCI by coronary pressure measurement. Heart. 2004;90:1085-
93. 
Pijls NH, de Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, Bartunek JKJ, Koolen JJ. Measurement 
of fractional flow reserve to assess the functional severity of coronary-artery stenosis. N Engl J Med. 
1996;334:1703-8. 
Pijls NH, van Gelder B, van der Voort P, Peels K, Bracke FA, Bonnier HJ, el Gamal MI. Fractional flow 
reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial 
blood flow. Circulation. 1995 Dec 1;92(11): 3183–93. 
Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, van't Veer M, Bär F, Hoorntje J, 
Koolen J, Wijns W, de Bruyne B. Percutaneous coronary intervention of functionally 
nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol. 2007 May 
29;49(21):2105-11. Epub 2007 May 17. 
Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining 
maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing 
functional stenosis severity before and after percutaneous transluminal coronary angioplasty. 
Circulation. 1993 Apr;87(4):1354-67. 
Pizzuto F, Voci P, Bartolomucci F, Puddu PE, Strippoli G, Broglia L, Rossi P. Usefulness of coronary 
flow reserve measured by echocardiography to improve the identification of significant left 
Esa Joutsiniemi 
 64
anterior descending coronary artery stenosis assessed by multidetector computed tomography. Am 
J Cardiol. 2009 Sep 1;104(5):657-64. doi: 10.1016/j.amjcard.2009.04.044. Epub 2009 Jun 24. 
Pradhan R, Chaudhary A, Donato AA. Predictive accuracy of ST depression during rapid atrial 
fibrillation on the presence of obstructive coronary artery disease. Am J Emerg Med. 2012 
Sep;30(7):1042-7. doi: 10.1016/j.ajem.2011.06.027. Epub 2011 Aug 19. 
Pryor DB, Harrell FE Jr, Lee KL, Califf RM, Rosati RA. Estimating the likelihood of significant coronary 
artery disease. Am J Med 1983;75:771-80. 
Raff GL, Gallagher MJ, O'Neill WW, Goldstein JA. Diagnostic accuracy of noninvasive coronary 
angiography using 64-slice spiral computed tomography. J Am Coll Cardiol. 2005 Aug 2;46(3):552-
7. 
Radiation dose to patients from radiopharmaceuticals: recalculated data for frequently used 
radiopharmaceuticals (addendum 2 to ICRP publication 53). Ann ICRP. 1998;28:1-126. 
Rizvi A, Han D, Danad I, Ó Hartaigh B, Lee JH, Gransar H, Stuijfzand WJ, Roudsari HM, Park MW, 
Szymonifka J, Chang HJ, Jones EC, Knaapen P, Lin FY, Min JK, Peña JM. Diagnostic Performance 
of Hybrid Cardiac Imaging Methods for Assessment of Obstructive Coronary Artery Disease 
Compared With Stand-Alone Coronary Computed Tomography Angiography: A Meta-Analysis. 
JACC Cardiovasc Imaging. 2018 Apr;11(4):589-599. doi: 10.1016/j.jcmg.2017.05.020. Epub 2017 
Aug 16 
Rossen JD, Winniford MD. Effect of increases in heart rate and arterial pressure on coronary flow 
reserve in humans. J Am Coll Cardiol. 1993 Feb;21(2):343-8. 
Sampson UK, Dorbala S, Limaye A, Kwong R, Di Carli MF. Diagnostic accuracy of rubidium-82 
myocardial perfusion imaging with hybrid positron emission tomography/computed tomography 
in the detection of coronary artery disease. J Am Coll Cardiol. 2007 Mar 13;49(10):1052-8. Epub 
2007 Feb 26. 
Saraste A, Kajander S, Han C, Nesterov SV, Knuuti J. PET: is myocardial flow quantification a clinical 
reality? J Nucl Cardiol. 2012;19:1044-59. 
Saraste M, Koskenvuo JW, Mikkola J, Pelttari L, Toikka JO, Hartiala JJ. Technical achievement: 
transthoracic Doppler echocardiography can be used to detect LAD restenosis after coronary 
angioplasty. Clin Physiol. 2000 Nov;20(6):428-33 
Saraste M, Vesalainen RK, Ylitalo A, Saraste A, Koskenvuo JW, Toikka JO, Vaittinen MA, Hartiala JJ, 
Airaksinen KE. Transthoracic Doppler echocardiography as a noninvasive tool to assess coronary 
artery stenoses--a comparison with quantitative coronary angiography. J Am Soc Echocardiogr. 
2005 Jun;18(6):679-85. 
Schenker MP, Dorbala S, Hong EC, Rybicki FJ, Hachamovitch R, Kwong RY, Di Carli MF. Interrelation 
of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate 
likelihood of coronary artery disease: a combined positron emission tomography/ computed 
tomography study. Circulation. 2008;117:1693-1700. 
Schindler TH, Schelbert HR, Quercioli A, Dilsizian V. Cardiac PET imaging for the detection and 
monitoring of coronary artery disease and microvascular health. J Am Coll Cardiol Img. 
2010;3:623-40. 
Sara Seitun, Cecilia De Lorenzi, Filippo Cademartiri, Angelo Buscaglia, Nicole Travaglio, Manrico 
Balbi, Gian Paolo Bezante. CT Myocardial Perfusion Imaging: A New Frontier in Cardiac Imaging. 
Biomed Res Int. 2018; 2018: 7295460. Published online 2018 Oct 14. doi: 10.1155/2018/7295460 
Sevag Packard RR, Dong Li, Matthew J. Budoff, Ronald P. Karlsberg. Fractional flow reserve by 
computerized tomography and subsequent coronary revascularization. Eur Heart J Cardiovasc 
Imaging. 2017 Feb; 18(2): 145–152. Published online 2016 Jul 28. doi: 10.1093/ehjci/jew148 
Shaw LJ, Hage FG, Berman DS, Hachamovitch R, Iskandrian A. Prognosis in the era of comparative 
effectiveness research: where is nuclear cardiology now and where should it be? J Nucl Cardiol. 
2012 Oct;19(5):1026-43. doi: 10.1007/s12350-012-9593-y. Review. No abstract available. Erratum 
in: J Nucl Cardiol. 2012 Oct;19(5):1092-3.  
Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti P, Poldermans D, Voigt J-U, 
Zamorano JL. Stress Echocardiography Expert Consensus Statement--Executive Summary: 
References 
 65 
European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur Heart J 
2009;30:278–289. 
Takx RA, Blomberg BA, El Aidi H, Habets J, de Jong PA, Nagel E, Hoffmann U, Leiner T. Diagnostic 
accuracy of stress myocardial perfusion imaging compared to invasive coronary angiography with 
fractional flow reserve meta-analysis. Circ Cardiovasc Imaging. 2015 Jan;8(1). pii: e002666. doi: 
10.1161/CIRCIMAGING.114.002666. Review.     
Tavakol M, Ashraf S, Brener SJ. Risks and complications of coronary angiography: a comprehensive 
review. Glob J Health Sci. 2012 Jan 1;4(1):65-93. doi: 10.5539/gjhs.v4n1p65 
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Joint ESC/ACCF/AHA/WHF 
Task Force for the Universal Definition of Myocardial Infarction, Katus HA, Lindahl B, Morrow 
DA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons 
RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand 
JP, Menasché P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons 
ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, 
Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, 
Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S. Third universal definition of 
myocardial infarction. Circulation. 2012 Oct 16;126(16):2020-35. doi: 
10.1161/CIR.0b013e31826e1058. Epub 2012 Aug 24. 
Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van' t Veer M, Klauss V, Manoharan G, 
Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF; FAME Study Investigators. 
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl 
J Med. 2009 Jan 15;360(3):213-24. doi: 10.1056/NEJMoa0807611. 
Tonino PA, Fearon WF, De Bruyne B, Oldroyd KG, Leesar MA, Ver Lee PN, Maccarthy PA, Van't Veer 
M, Pijls NH. Angiographic versus functional severity of coronary artery stenoses in the FAME 
study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol. 2010 
Jun 22;55(25):2816-21. doi: 10.1016/j.jacc.2009.11.096. 
Tweet MS, Arruda-Olson AM, Anavekar NS, Pellikka PA. Stress echocardiography: what is new and 
how does it compare with myocardial perfusion imaging and other modalities? Curr Cardiol Rep. 
2015 Jun;17(6):43. doi: 10.1007/s11886-015-0600-1. 
Uren NG, Melin JA, De Bruyne B, Wijns W, Baudhuin T, Camici PG. Relation between myocardial 
blood flow and the severity of coronary-artery stenosis. N Engl J Med. 1994 Jun 23;330(25):1782-8. 
Vegsundvåg J, Holte E, Wiseth R, Hegbom K, Hole T. Transthoracic echocardiography for imaging of 
the different coronary artery segments: a feasibility study. Cardiovasc Ultrasound. 2009 Dec 22;7:58. 
doi: 10.1186/1476-7120-7-58. 
Verberne HJ, Acampa W, Anagnostopoulos C, Ballinger J, Bengel F, Bondt P De, Buechel RR, Cuocolo 
A, Eck-Smit BLF van, Flotats A, Hacker M, Hindorf C, Kaufmann PA, Lindner O, Ljungberg M, 
Lonsdale M, Manrique A, Minarik D, Scholte AJHA, Slart RHJA, Trägårdh E, Wit TC de, Hesse B, 
European Association of Nuclear Medicine (EANM). EANM procedural guidelines for 
radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision. Eur J Nucl 
Med Mol Imaging 2015;42:1929–1940. PMID:26290421 
Watanabe N, Akasaka T, Yamaura Y, Akiyama M, Koyama Y, Kamiyama N, Neishi Y, Kaji S, Saito Y, 
Yoshida K. Noninvasive detection of total occlusion of the left anterior descending coronary artery 
with transthoracic Doppler echocardiography. J Am Coll Cardiol. 2001 Nov 1;38(5):1328-32. 
Wener J, Sandberg AA, Scherlis L, Dvordin J, Master AM. The electrocardiographic response to the 
standard 2-step exercise test. Can Med Assoc J. 1953 Apr;68(4):368-74. 
Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, 
Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte 
P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A. 
Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard 
R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, 
Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, 
Wijns W, Windecker S, Sousa Uva M, Achenbach S, Pepper J, Anyanwu A, Badimon L, Bauersachs 
J, Baumbach A, Beygui F, Bonaros N, De Carlo M, Deaton C, Dobrev D, Dunning J, Eeckhout E, 
Esa Joutsiniemi 
 66
Gielen S, Hasdai D, Kirchhof P, Luckraz H, Mahrholdt H, Montalescot G, Paparella D, Rastan AJ, 
Sanmartin M, Sergeant P, Silber S, Tamargo J, Ten Berg J, Thiele H, van Geuns RJ, Wagner HO, 
Wassmann S, Wendler O, Zamorano JL, Weidinger F, Ibrahimov F, Legrand V, Terzic I, 
Postadzhiyan A, Skoric B, Georgiou GM, Zelizko M, Junker A, Eha J, Romppanen H, Bonnet JL, 
Aladashvili A, Hambrecht R, Becker D, Gudnason T, Segev A, Bugiardini R, Sakhov O, 
Mirrakhimov A, Pereira B, Felice H, Trovik T, Dudek D, Pereira H, Nedeljkovic MA, Hudec M, 
Cequier A, Erlinge D, Roffi M, Kedev S, Addad F, Yildirir A, Davies J. 2014 ESC/EACTS Guidelines 
on myocardial revascularization: The Task Force on Myocardial Revascularization of the European 
Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery 
(EACTS)Developed with the special contribution of the European Association of Percutaneous 
Cardiovascular Interventions (EAPCI). Eur Heart J. 2014 Oct 1;35(37):2541-619. doi: 
10.1093/eurheartj/ehu278. Epub 2014 Aug 29. 
Williams MC, Hunter A, Shah AS, Assi V, Lewis S, Smith J, Berry C, Boon NA, Clark E, Flather M, 
Forbes J, McLean S, Roditi G, van Beek EJ, Timmis AD, Newby DE; SCOT-HEART Investigators 
Use of Coronary Computed Tomographic Angiography to Guide Management of Patients With 
Coronary Disease. J Am Coll Cardiol. 2016 Apr 19;67(15):1759-68. doi: 10.1016/j.jacc.2016.02.026 
Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD. Effects of adenosine on human coronary 
arterial circulation. Circulation. 1990;82:1595-1606. 
Yoshinaga K, Chow BJ, Williams K, Chen L, deKemp RA, Garrard L, Lok-Tin Szeto A, Aung M, Davies 
RA, Ruddy TD, Beanlands RS. What is the prognostic value of myocardial perfusion imaging using 
rubidium-82 positron emission tomography? J Am Coll Cardiol. 2006 Sep 5;48(5):1029-39. Epub 
2006 Aug 17. 
Yoshinaga K, Katoh C, Noriyasu K, Iwado Y, Furuyama H, Ito Y, Kuge Y, Kohya T, Kitabatake A, 
Tamaki N. Reduction of coronary flow reserve in areas with and without ischemia on stress 
perfusion imaging in patients with coronary artery disease: a study using oxygen 15-labeled water 
PET. J Nucl Cardiol. 2003 May-Jun;10(3):275-83. 
Ziadi MC, deKemp RA, Williams KA, Guo A, Chow BJW, Renaud JM, Ruddy TD, Sarveswaran N, Tee 
RE, Beanlands RSB. Impaired Myocardial Flow Reserve on Rubidium-82 Positron Emission 
Tomography Imaging Predicts Adverse Outcomes in Patients Assessed for Myocardial Ischemia. 
Journal of the American College of Cardiology, Volume 58, Issue 7, 2011, pp. 740-8 
Ziadi MC, Dekemp RA, Williams K, Guo A, Renaud JM, Chow BJ, et al. Does quantification of 
myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of 
multivessel coronary artery disease? J Nucl Cardiol 2012;19:670-80 
 
Imaging
Cardiac Positron Emission Tomography/Computed
Tomography Imaging Accurately Detects Anatomically and
Functionally Significant Coronary Artery Disease
S. Kajander, MD; E. Joutsiniemi, MD; M. Saraste, MD; M. Pietila¨, MD, PhD; H. Ukkonen, MD, PhD;
A. Saraste, MD, PhD; H.T. Sipila¨, PhD; M. Tera¨s, PhD; M. Ma¨ki, MD, PhD; J. Airaksinen, MD, PhD;
J. Hartiala, MD, PhD; J. Knuuti, MD, PhD
Background—Computed tomography (CT) is increasingly used to detect coronary artery disease, but the evaluation of
stenoses is often uncertain. Perfusion imaging has an established role in detecting ischemia and guiding therapy. Hybrid
positron emission tomography (PET)/CT allows combination angiography and perfusion imaging in short, quantitative,
low-radiation-dose protocols.
Methods and Results—We enrolled 107 patients with an intermediate (30% to 70%) pretest likelihood of coronary artery
disease. All patients underwent PET/CT (quantitative PET with 15O-water and CT angiography), and the results were
compared with the gold standard, invasive angiography, including measurement of fractional flow reserve when
appropriate. Although PET and CT angiography alone both demonstrated 97% negative predictive value, CT
angiography alone was suboptimal in assessing the severity of stenosis (positive predictive value, 81%). Perfusion
imaging alone could not always separate microvascular disease from epicardial stenoses, but hybrid PET/CT
significantly improved this accuracy to 98%. The radiation dose of the combined PET and CT protocols was 9.3 mSv
(86 patients) with prospective triggering and 21.8 mSv (21 patients) with spiral CT.
Conclusion—Cardiac hybrid PET/CT imaging allows accurate noninvasive detection of coronary artery disease in a
symptomatic population. The method is feasible and can be performed routinely with 10 mSv in most patients.
Clinical Trial Registration—URL: http://www.clinicaltrials.gov. Unique identifier: NCT00627172.
(Circulation. 2010;122:603-613.)
Key Words: computed tomography  coronary disease  imaging  perfusion  positron emission tomography
Accurate noninvasive assessment of coronary artery dis-ease (CAD) is challenging. Several imaging techniques
such as single-photon emission tomography (SPECT), stress
echocardiography, magnetic resonance imaging, and positron
emission tomography (PET) have been used to detect myo-
cardial ischemia.
Clinical Perspective on p 613
Computed tomography (CT) enables visualization of cor-
onary stenoses. Meta-analyses show that CT can rule out the
presence of CAD while positive predictive values (PPVs) are
moderate.1–3 Of the 2 multicenter trials published, 1 study
was consistent with the results of meta-analyses,4 and the
other showed only mediocre negative predictive value (NPV)
for CAD.5
Although CT is able to assess coronary artery lumen, there
may be a discrepancy between anatomy and myocardial
blood supply. The vasomotor tone and coronary collateral
flow cannot be estimated because the degree of stenosis is
only a weak descriptor of coronary resistance.6 Therefore,
only about half of the anatomically significant lesions de-
tected with CT coronary angiography (CTA) are flow limit-
ing. Meijboom et al4 reported 49% accuracy of CTA in
predicting reduced fractional flow reserve (FFR), whereas
Gaemperli and colleagues7 found that 50% of the lesions in
CTA were associated with perfusion defects in SPECT.
Functional assessment is needed, particularly in the evalua-
tion of intermediate lesions,8–10 and therapy for nonsignifi-
cant stenoses can be deferred.11–14 The measurement of FFR
during invasive coronary angiography (ICA) has been used as
a gatekeeper for angioplasty.11–14
Although the use of FFR is likely to increase, its invasive-
ness and cost warrant noninvasive alternatives. Combined
imaging of coronary anatomy and perfusion is possible with
commonly available hybrid PET/CT scanners. With PET/CT,
the location, severity, and composition of the plaques and
Continuing medical education (CME) credit is available for this article. Go to http://cme.ahajournals.org to take the quiz.
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